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Abstract 
Background 
STIs are of major public health concern in developing countries, not least because they 
facilitate transmission of HIV, but also because they are important causes of mortality 
and morbidity among African populations, resulting in, among other things, adverse birth 
outcomes, neonatal and infant infections, ectopic pregnancy, anogenital cancer, 
infertility, pelvic inflammatory disease, and death. Thus, effective treatment needs to be 
prompt and accurate to control the spread, and morbidity and mortality of STIs. Even 
though syndromic approach to the management of STIs is effective, most evaluations 
have focused on syndromic STI management within STI clinics as opposed to research 
studies. Partner notification is an integral component of the syndromic approach and is 
aimed at preventing onward transmission of infection as well as re-infection. It includes 
informing sexual partners of infected people of their exposure, administering presumptive 
treatment, and providing advice about the prevention of future infection. 
Methods 
This is a cross sectional descriptive study based on a retrospective review of STI data of 
study participants in KICoS aged 18 to 34 years. A non probability convenience sampling 
method was used to recruit study participants. A total of 1,277 participants were pre-
screened into KICoS of whom 847 were enrolled into this study. Data was collected 
using CAPI and ACASI questionnaires as well as Teleforms which was analysed in SAS 
for windows 9.1.  
Results 
Syndromic prevalence of STIs was 5.7% while the aetiological prevalence was 32.8%. 
Risk factors to STI acquisition included, being female, having multiple sexual partners, 
having lower than tertiary education, using recreational drugs and being HIV. Agreement 
between the interviewing methods as well between the syndromic and laboratory 
diagnosis ranged from fair to substantial. This was also true for the agreement between 
laboratory and CAPI as well as between the laboratory and ACASI. Sensitivity was 
generally low while specificity was high. Uptake of contact tracing cards was high 
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though with very low uptake of contact treatment with only 2.1% and 0.4% partners of 
the syndromically and aetiologically diagnosed participants coming for treatment. 
Conclusions 
STI is a problem in this community and thus there should be more emphasis on risk 
reduction messages in patient education to mitigate the spread of STIs. The performance 
of syndromic management was very poor against the aetiological diagnosis thus there 
needs to further review the use of syndromic diagnosis of STIs in research settings. 
Partner tracing needs to be intensified since there was very poor partner treatment even 
with high uptake of contact cards. 
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1. INTRODUCTION 
1.1. Background 
“Sexually Transmitted Infections (STIs) are a major global cause of acute illness, 
infertility, long term disability and death, with severe medical and psychological 
consequences for millions of men, women and infants (WHO, 2001a).” 
More than 30 bacterial, viral and parasitic pathogens are sexually transmitted with STIs 
being transmitted mostly through sex (WHO, 2007). STIs are of major public health 
concern in developing countries, not least because they facilitate transmission of Human 
Immunodeficiency Virus (HIV) (Laga et al., 1993, Cohen et al., 1997, Gilson et al., 1997, 
Wawer et al., 1999, Kamali et al., 2003, WHO, 1999, Mayaud et al., 1997), but also 
because they are important causes of mortality and morbidity among African populations, 
resulting in, among other things, adverse birth outcomes, neonatal and infant infections, 
ectopic pregnancy, anogenital cancer, infertility, pelvic inflammatory disease, and death 
(Buve et al., 1993, WHO, 2003, WHO, 2005, WHO, 2007). Thus, effective treatment 
needs to be prompt and accurate to control the spread, and morbidity and mortality of 
STIs (WHO, 2007). 
Proper management of STIs should include strategies for patient screening and notifying 
their sexual partners, mono-dose and simplified therapies to improve compliance, and 
increase accessibility of services (Catchpole, 2001). Over the years, the management of 
STIs has improved considerably with introduction of new diagnostic tools as well as 
algorithms. The World Health Organisation (WHO) gives recommendations on these 
diagnostic tools and algorithms and different regions and countries are expected to adapt 
them to their situations (WHO, 2003, WHO, 2005, WHO, 2008). Even though 
aetiological diagnosis is considered to be the gold standard for diagnosis and 
management of STIs (Workowski et al., 2002), syndromic management is presented as a 
simplified and affordable approach that does not involve extra clinic visits, which may 
result in treatment delays (WHO, 2005). In 1985, the WHO developed simplified STI 
treatment guidelines at primary healthcare levels, which it revised severally and now 
recommends a purely syndromic approach to STI management (WHO, 2003).  
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Syndromic management of STIs is the diagnosis and treatment of STIs based on 
identification and treatment of a group of symptoms and signs (syndromes) associated 
with a number of well defined causative organisms. Following identification of the 
syndrome, treatment is provided to cover majority of the organisms that can cause the 
syndrome. This approach allows health workers to make diagnosis of the STIs without 
sophisticated laboratory tests thus allowing for faster and easier management. This 
information if further simplified and presented to health workers in easy to interpret flow 
charts both for diagnosis and treatment (WHO, 2003, WHO, 2005, WHO, 2008). 
1.2. Problem Statement 
Even though literature shows that syndromic approach to the management of STIs is 
effective (Mayaud et al., 1997, Mbofana et al., 2002, Wolday et al., 2004, Pickering et al., 
2005), most of these evaluations have focused on syndromic STI management within STI 
clinics as opposed to research studies. Typically, STI clinic patients present with 
constitutional signs and symptoms while research study participants are asked a battery of 
questions about specific symptoms with the goal of providing treatment. Syndromic 
questions are based on WHO (2005) classification; urethritis/cervicitis and pelvic 
inflammatory disease (PID) for gonorrhoea and chlamydia, vaginitis for candida and 
trichomonas, and genital ulcer disease (GUD) for syphilis and herpes simplex virus type 
2 (HSV-2).  
Not all people with STIs are symptomatic and not all those that are symptomatic 
recognize the meaning or importance of their symptoms. Thus many are treated for STIs 
they did not have and those who unknowingly have STIs go without being treated 
resulting in cases of under-treatment or overtreatment (Wilkinson et al., 1999, Wolday et 
al., 2004, Panchanadeswaran et al., 2006, Grosskurth et al., 2000, Malta et al., 2007). 
Asymptomatic cases are patients who have been infected with STIs but have not yet 
manifested signs and symptoms of STIs. Those who are asymptomatic may continue 
transmitting the STIs unknowingly as they may not have been diagnosed and treated. 
Within this transmitting group, there are three subgroups of sexually active infected 
individuals: (1) those who have sought health care but have been inadequately diagnosed, 
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treated, and/or counselled; (2) those who are symptomatic but are delaying seeking health 
care; and (3) those who are asymptomatic (Abdool Karim, 1994). Effective management 
would need to be offered to all these groups to stem the tide of the infections. 
Since syndromic diagnosis is being carried out within a research context, it is important 
to determine if it is a sufficient tool for diagnosing STIs or if it must be paired with 
laboratory testing.  
1.3. Aim and Objectives 
The aim of this study was to investigate the prevalence of, describe the risk factors 
associated with and to evaluate the performance syndromic diagnosis in the management 
of STIs within the Kisumu Incidence Cohort Study (KICoS) in Kisumu, Kenya. 
The objectives of the study were as follows: 
1. To estimate the prevalence of STIs within KICoS using both laboratory and 
syndromic diagnosis 
2. To describe the risk factors associated with STIs within KICoS  
3. To evaluate the performance of STI syndromic diagnosis against aetiological 
laboratory diagnosis within KICoS 
4. To establish the performance of partner contact treatment in the management of STIs 
within KICoS 
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2. LITERATURE REVIEW 
2.1. Prevalence of STIs 
The prevalence and incidence of STIs has been on the rise over the years. The WHO 
estimated 340 million incident cases of syphilis, gonorrhoea, chlamydia and 
trichomoniasis in men and women aged 15-49 years in 1999 worldwide. This was an 
increase from approximately 250 million new cases in 1990 (WHO, 2001a). Sub Saharan 
Africa continues bearing the brunt of these infections with 69 million people being newly 
infected with these STIs in a population of 269 million adults aged 15–49 years (WHO, 
2001a). HSV-2 is more prevalent with 30% to 80% of women and 10% to 50% of men in 
sub Saharan Africa being infected (Holmes et al., 1999). 
With very few population-based prevalence and incidence studies, majority of studies 
have been based on sentinel surveillance of sentinel populations in STI clinics and 
antenatal clinics as well as commercial sex workers and other at risk populations. The 
populations at risk continues to grow dynamically due to the social, demographic and 
migratory trends (Holmes et al., 1999). Antenatal sentinel surveys in Central African 
Republic and Malaysia found the prevalence of Chlamydia to be 6.2% and 1.6% 
respectively while that of gonorrhoea was 3.1% and 0.2% respectively. The studies also 
found the prevalence of syphilis to be 6.7% and 0.3% respectively (Blankhart et al., 1999, 
WHO, 2001c). 
Commercial sex workers (CSW) surveillance in Malaysia found the prevalence of STIs to 
be comparable to that of antenatal clinic attendees in Central African Republic save for 
syphilis which was very high at 30.8% (WHO, 2001c). Another CSW sentinel survey in 
Malawi that focused on syndromically diagnosed STIs found the prevalence to be high 
with GUD, PID and urethritis having prevalences of 21%, 24% and 53% respectively 
(Zachariah et al., 2003). Another sentinel survey among post abortal clinic attendees in 
Mozambique found higher prevalence of Chlamydia (42.5%), gonorrhoea (32.9%) and 
syphilis (7.9%) (Machungo et al., 2002). 
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A population-based prevalence and incidence study of syphilis and sexually transmitted 
disease syndromes in north-western Tanzania found the prevalence of syphilis to be 8.1% 
for males and 9.4% for females. It also found the prevalence of GUD to be 14.4% for 
men and 4.2% for women while 28.0% of males and 7.1% of females reported to be 
having urethral or abnormal vaginal discharge. The study also found the overall one year 
incidences of GUD to be 3.6% in men and 2.0% in women, and those of urethral or 
abnormal vaginal discharge as 6.8% and 4-4% for men and women respectively, again 
twice those of GUS (Mosha et al., 1993). 
The four cities study in Cotonou, Yaounde, Kisumu, and Ndola reported the prevalence 
of HSV-2 to be over 50% among women and over 25% among men in Yaounde, Kisumu 
and Ndola, with notably high rates of infection among young women aged 15-19 years in 
Kisumu (39%) and Ndola (23%). The prevalence in Cotonou was lower with 30% of 
women and 12% of men being infected (Weiss et al., 2001).  
Another population based prevalence study in Indonesia found the prevalence of 
Chlamydia (<1%,), gonorrhoea (1.7%) and syphilis (5.2%) (Sabin et al., 2003) to be 
lower than that of South Africa which found the prevalence of Chlamydia to be 6.1%, 
that of gonorrhoea to be 4.5% and that of syphilis to be 8.8% (Colvin et al., 1998). A 
seroprevalence study in Gabon found very high prevalence of Chlamydia (59.6%) and 
syphilis (8.6%) (Bertherat et al., 1998). A study among ANC attendees in 6 different 
clinics in Tanzania reported the prevalence of HSV-2 to be 20.7% and that of syphilis to 
be 1.6% (Yahya-Malima et al., 2008). 
In a male cohort study in Rakai Uganda (Charvat et al., 2009), the prevalence of HSV-2 
infection was 33.76%. A study in Malawi assessing the prevalence of HSV-2 among 4 
cohorts found the prevalence to be higher ranging from 33.2% to 42.1% among the males 
and from 47.6% to 66.7% among females in the different cohorts (Glynn et al., 2008). In 
a high risk female cohort study in Tanzania, the prevalence of HSV-2 was found to be 
very high with 80% of the females being infected (Watson-Jones et al., 2007). This was 
close to a HSV-2 prevalence study in STD clinics in Tanzania which found the 
prevalence in males to be 35.5% and that for females to be 63% (Langeland et al., 1998). 
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Though there are not very many studies showing STI co-infection among study 
populations, some studies have documented this phenomenon with patients having two or 
more STIs concurrently. A study in china found co infection with gonorrhoea and 
Chlamydia to be prevalent amongst commercial sex workers (25%) and truck drivers 
(2%) with the highest prevalence of chlamydial or gonorrhoeal infection being observed 
among the 15-19 and the 19-24 age groups (WHO, 2001b). another study of 
genitourinary clinic attendees in Edinburg Scotland found that 7.3% of the study 
population had concurrent STI infection (Pakianathan et al., 1996). 
2.2. Syndromic Management of STIs 
The WHO recommends syndromic management as the first line management of 
uncomplicated STIs in resource-limited settings as well as in resource-rich settings 
dependent on circumstances (WHO, 2003, WHO, 2005). This approach involves the use 
of simple flowcharts to help health-care workers identify groups of symptoms and easily 
recognisable signs (syndromes) and guide treatment consisting of combination antibiotics 
likely to cover the most probable causes of the syndrome (Donovan, 2004, Low et al., 
2006, WHO, 2003). The WHO further encourages countries or regions to adapt the 
algorithms and flow charts to fit their region or country-specific needs. 
Though aetiological diagnosis and management is considered as the gold standard of STI 
treatment, laboratory testing for STIs is quite expensive with costs ranging from $6-89 
for chlamydia trachomatis DNA, $1-89 for neisseria gonorrhoeae DNA, $12 for 
trichomonas vaginalis, $20-100 for bacterial vaginosis, $35-159 for HSV2 and $1-60 for 
syphilis (Peeling, 2006, Donovan, 2004). Also since most countries, especially 
developing countries, do not require regulatory approval for use of these tests in their 
regions, their validation in these regions becomes difficult with a resultant proliferation 
of even obsolete testing algorithms (Peeling, 2006). 
It is on the back of this that the syndromic approach appears useful as it removes the need 
for laboratory testing and to an extent, even the need for physical examination (Donovan, 
2004). This approach is seen as a practical strategy for use in resource-limited settings as 
it provides prompt treatment thus avoiding loss to follow up that could be witnessed in 
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STI management involving laboratory-based diagnosis (Low et al., 2006). In addition, 
this approach is sometimes necessary in resource-rich environments, such as in cases of 
upper genital tract infections where detection of the pathogen is difficult (Donovan, 
2004). 
Syndromic management is based on the ability of the health workers to remember the 
guidelines as well as the client’s ability to recall and correctly describe the signs and 
symptoms which would fit into a specific syndrome. Those opposing the syndromic 
approach argue that it contributes to health workers being de-skilled as the procedures 
become routine to them thus they are reduced to robotic creatures (Garg et al., 2007). 
These opponents further point out that it does little to reduce the numerically dominant 
subclinical pool of STIs as patients in this category are still asymptomatic (Donovan, 
2004, Mullick et al., 2005). In symptomatic patients, most symptoms are highly 
inconsistent in their positive predictive power for the STIs with expensive antibiotics 
being wasted at times with the risk of promoting resistance. The liberal use of antibiotics 
most of the time results in the development of resistance to the antibiotics with resultant 
treatment failure or change to more expensive antibiotics (Workowski et al., 2008).  
Several studies (Chalamilla et al., 2006, Pépin et al., 2004, Low et al., 2006, Desai et al., 
2003, Donovan, 2004, Kamali et al., 2003) have demonstrated syndromic management as 
being effective in the management of STIs in males, especially in the case of gonorrhoea 
and chlamydia infections. This on the other hand, is not true for females with only a 
minority receiving the correct syndromic management of both infections. These studies 
and others (Goh, 2005, Mosha et al., 1993) further found out that treatment guidelines for 
GUD against aetiological diagnosis was also poor with many patients being treated for 
syphilis and or chancroid which they did not have. The studies also found out that there 
were some cases of misreporting with patients reporting to have ulcers when actually 
they have discharge and vice versa. 
Even though some studies have shown that reported symptoms of STIs in the past 12 
months were high for both men and women, these same studies have also reported that 
the overall awareness level about STIs and their prevention was rather low with as many 
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as 70% of the study participants being unable to mention even one symptom of an STI 
(Garg et al., 2007, Hawken et al., 2002). These studies also observed poor treatment 
seeking behaviours among the participants and their partners. 
2.3. Partner Contact Tracing 
The one day treatment regimen allows for an opportunity for health promotion as well as 
prevention services with partner notification being a key factor (Low et al., 2006). Partner 
notification is an integral component of the syndromic approach and is aimed at 
preventing onward transmission of infection as well as re-infection (WHO, 2003, Low et 
al., 2006). It includes informing sexual partners of infected people of their exposure, 
administering presumptive treatment, and providing advice about the prevention of future 
infection. Studies have shown that the risk of re-infection or persistent infection in index 
cases can also be reduced with correct partner notification (Mullick et al., 2005, Low et 
al., 2006, Workowski et al., 2008).  
A study in South Africa found that most female patients preferred to deliver medication 
to their partners as opposed to informing them to go for treatment to a clinic. This was 
mainly because they felt their partners would not have time or would not want to go to the 
clinic. In addition, they felt this was a way to ensure that partners received treatment 
(Young et al., 2007). Another study in Kenya (Wakasiaka et al., 2003) found that only 
23% of their patients ever refereed their partners for STI management. They also found 
that patients with multiple sex partners were less likely to refer their partners and that 
counselling of STI patients on the importance of partner referral was more effective than 
issuing referral cards alone. 
One of the major challenges in partner notification is the identification and provision of 
epidemiological treatment to sexual partners (Wilkinson et al., 1999, Goh, 2005). This 
has seen periodic presumptive treatment being provided in some risk group with better 
success (Steen et al., 2000). Even in centres that provide partner notification (Manavi et 
al., 2008), uptake has been low with a survey of 13 centres providing partner notification 
reporting an average of 32% partner notification. 
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A survey of physicians in the United States (St. Lawrence et al., 2002, St.Lawrence et al., 
2002) found out that physicians would rather have the patients notify their partners than 
the physicians doing so. This actually negates the possibility of confirming whether the 
partner notification was done and subsequent treatment administered correctly. Another 
challenge has been the internet based STI treatment sites which offer information on 
products for STI treatment (Vivancos et al., 2007). These sites however seldom provided 
advice on treatment of sexual contacts or on preventive measures. 
2.4. Risk Factors of STIs 
STI infection has been associated with different risk factors and a change in these risk 
factors is almost always accompanied by a significant decrease in the incidence of STIs 
(Jackson et al., 1997). Several studies have demonstrated different risk factors to be 
associated with different STIs with some of them cutting across some infections. 
Different studies have shown that HIV co-infection increases the chances of getting STIs 
and vice versa. A study in Addis Ababa found that HIV co-infection predisposes women 
to getting more ulcerative STIs as well as failing STI treatment especially HSV-2 
(Wolday et al., 2004). This was also seen in another study in Tanzania that enrolled high 
risk females (Watson-Jones et al., 2007) and the four cities study in Cotonou, Yaounde, 
Kisumu and Ndola (Weiss et al., 2001). Another study in Malaysia also found HIV as a 
predisposing factor to syphilis among female and male sex workers (WHO, 2001c). A 
study in Malawi that followed four cohorts found that HSV-2 infection was not 
significantly affected by HIV infection (Glynn et al., 2008), and another male cohort 
study in Rakai found enrolment of HIV status not to significantly affect acquisition of 
HSV-2 (Charvat et al., 2009). The Rakai study also found that male circumcision reduced 
the risk of HSV-2 acquisition. Consistent condom use was also shown to be protective 
against the acquisition of HSV-2 (Watson-Jones et al., 2007, Yahya-Malima et al., 2008, 
Charvat et al., 2009) 
Age has been shown to be a risk factor to the acquisition of STIs with different studies. 
Fenton et al., (2005) found that younger people were more at risk to acquire STIs than 
adults as was also seen in a study in Malawi (Glynn et al., 2008). This is also true in 
another study among antenatal women that found younger women to be more at risk of 
 
 
 
 
UWC, SOPH Mini-thesis. Fredrick O Otieno, 2632337.   September 2009         11
having Chlamydia than their older counterparts (WHO, 2001c). On the other hand, a 
study in Tanzania (Newell et al., 1993) found very little to no association between age 
and STIs. Other studies in Edinburgh (Pakianathan et al., 1996), Cotonou, Yaunde, 
Kisumu and Ndola (Weiss et al., 2001) and Tanzania (Watson-Jones et al., 2007) found 
older age to be more associated with STI acquisition. 
Several studies have looked at the effect of gender on STI acquisition with men being 
found to be more at risk of acquiring STIs as opposed to their female counterparts. Sabin 
et al., (2003) found men to be twice at risk of being infected with STIs compared to 
females. A study looking at risk factors to STIs in Western Tanzania not only found men 
to be more at risk of acquiring STIs, it also found that among the men, age, education, 
marital status, residence near brothels and exchanging money for sex were the factors 
putting them at a higher risk of STI acquisition (Newell et al., 1993). The study also 
found that divorced, separated or widowed men as well as those with higher educational 
status had an increased risk of STIs while this was not true to females. A Malawi study 
looking at HSV-2 prevalence among four cohorts found that HSV-2 prevalence was 
higher in females than in males with antenatal women having a lower prevalence than 
those in the general population (Glynn et al., 2008). 
Education has been found to be a significant factor in STI transmission. A study in 
Tanzania found that educated women were less likely to be infected with syphilis while 
this was not true for men (Newell et al., 1993). On the other hand, educated men were 
more likely to have urethral discharge and genital ulcers compared to females. A CSW 
study also found that education had a protective effect in the acquisition of STIs with 
CSWs with lower education having more STIs and engage in more risky behaviours than 
their counterparts who are more educated (Solomon et al., 2008). This was also seen in a 
female high risk cohort study in Tanzania (Watson-Jones et al., 2007). 
Separation, divorce or widowhood was found to put men at risk of acquiring STIs 
compared to those who were married or living as married while being single was found to 
be more protective. Women on the other hand had less marked differences based on 
marital status (Newell et al., 1993, Zachariah et al., 2003). The number of sexual partners 
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has also been found to be a risk factor with sexual concurrency (Drumright et al., 2004) 
and sexual networks (Doherty et al., 2005) showing that the more the number of sexual 
partners, the more the risk of STI acquisition (Newell et al., 1993, Colvin et al., 1998, 
Weiss et al., 2001, Fenton et al., 2005, Yahya-Malima et al., 2008, Charvat et al., 2009). 
These studies also showed that low condom use also increased the risk of having STIs. 
Socio-economic class also plays a key role in the transmission of STIs with some studies 
(Fenton et al., 2005) showing no impact while others (Pakianathan et al., 1996, Watson-
Jones et al., 2007) showing an impact on the transmission of STIs. Employment generally 
is protective against STI acquisition, but other occupations like being a house help or an 
immigrant worker predispose to higher chances of STI acquisition (Newell et al., 1993, 
Smith Fawzi et al., 2003). 
Transactional sex and homosexuality have been shown to put people at risk of getting 
STIs with men living close to a brothel or bar also having a higher risk of acquiring STIs 
(Hughes et al., 2000, Noell et al., 2001, WHO, 2001c, Zachariah et al., 2003, Fenton et 
al., 2005). Other studies (Noell et al., 2001, Kraut-Becher and Aral, 2006) also found 
trans-generational sex to predispose people to acquire more STIs. Circumcision is 
protective especially from ulcerative STIs (Newell et al., 1993, Jansen et al., 2003), while 
it also predisposes the men to an increased risk of urethral discharge (Newell et al., 
1993).  
Injection drug use increases the risk of STI acquisition generally (Noell et al., 2001, 
Fenton et al., 2005). Different studies have also shown alcohol as a risk factor to the 
acquisition of STIs. In addition, alcohol intake was also associated with other risky 
sexual behaviours that also predispose to STI acquisition (Madhivanan et al., 2005, 
Kalichman et al., 2007, Chersich et al., 2007). 
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3. STUDY DESIGN AND METHODOLOGY 
3.1. Study Design 
This is a cross sectional descriptive study based on a retrospective review of STI data of 
study participants in KICoS. 
3.2. Study Population 
This study was set within KICoS which is a prospective cohort study to estimate 
incidence of HIV seroconversion and to identify determinants of successful recruitment 
and retention among adolescents and young adults in Kisumu, western Kenya (Chege et 
al., 2007). Participants in KICoS were young healthy adults aged 18-34 years. Other 
eligibility criteria for KICoS included being a resident of Kisumu, having had sexual 
intercourse at least once in the past three months and not being pregnant for females. 
Participants in KICoS were screened for STIs including gonorrhoea, Chlamydia, syphilis 
and HSV-2. In addition, those presenting with signs and symptoms of any of the STIs 
receive syndromic management with definitive treatment offered as necessary two weeks 
later after laboratory results become available. Participants receiving syndromic or 
definitive treatment are given contact treatment cards to give their sexual partners to 
facilitate their coming to the clinic for anonymous STI treatment (Chege et al., 2007).  
A non probability convenience sampling method was used to recruit study participants 
into KICoS. This approach did not provide a representative sample but ensured the 
identification of persons with a willingness to participate in a prospective study requiring 
multiple encounters with study staff. For KICoS, a sample size of 625 participants was 
calculated based on an estimated incidence 2.0 to 3.0 per 100 person-years and a 
retention rate of 80%.  
3.3. Inclusion and Exclusion Criteria 
To be included in this study, participants must have completed all the screening processes 
within KICoS, had STI testing and completed the behavioural questionnaire. Participants 
who did not have STI tests done or did not complete the behavioural questionnaire were 
excluded from this study.  
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3.4. Sampling 
A total of 1,277 participants were pre-screened into KICoS of whom 68% were eligible 
to complete the screening procedures based on the inclusion and exclusion criteria for 
KICoS as explained in section 3.2 above. Of those completing screening procedures, 20 
participants were excluded from this study because they were missing medical 
examination, pre screening, behavioural or laboratory data. This left a total of 847 
participants who met the inclusion criteria and were thus included in this study. This is 
shown in figure 1 below. This sample size provides a good precision with confidence 
intervals around 0.0381 – 0.0697 to detect 5% STI prevalence or 0.0989 – 0.1445 to 
detect 12% prevalence.  
 
 
Figure I: Flow Chart Showing Participant Enrolled into the Study 
3.5. Data Collection 
In KICoS, participant information was obtained using Audio Computer Assisted Self 
Interviews (ACASI) and Computer Assisted Personal Interviews (CAPI). These two 
forms of questionnaire designs are paperless and allow for direct data entry into a 
computer thus reducing redundancy and risk of transcription errors. The data collected 
was then exported to a Questionnaire Development System® (QDS) (Nova, 2008) 
warehouse manager where it was stored for analysis.  
Pre-screened 
1277 
KICoS Ineligible 
410 (32%) 
KICoS Eligible 
867 (68%) 
Included into Study 
847 (98%) 
Excluded from Study 
20 (2%) 
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Behavioural and demographic information was collected using ACASI which allowed the 
respondents to personally complete the study questionnaire by entering their responses 
directly into the computer via a touch screen. The behavioural questionnaire included 
questions on sexual debut, transactional sex, number of sexual partners, length of 
relationships, condom use, drug use during sex, anal or vaginal sex, circumcision status 
and symptoms and treatment history of STIs. Demographic information including 
education level, economic status as well as marital status was also collected on the 
ACASI questionnaire. Extracts from this questionnaire is included in Appendix A.  
Other demographic information including age, gender and residence was collected on the 
CAPI pre-screening questionnaire in which the study staff entered the participant’s 
responses directly to a computer in real time using the keyboard and mouse (Appendix 
B). Information on symptoms of STIs as well as diagnosis and treatment offered was 
collected using the CAPI medical history and physical examination questionnaire 
(Appendix C), after which the clinicians then fitted these responses within the syndromic 
classification as per the Kenya national guidelines for syndromic management of STIs 
(NASCOP, 1994). 
Laboratory diagnosis was based on different assays. BD Micro-Vue RPR Card test 
(Becton Dickinson company®) and Serrodia- TPPA (Fujirebio Diagnostics,Inc®) for 
Treponema Pallidum and HSV-2 IgG ELISA (KALON BIOLOGICAL LTD®) for 
herpes simplex virus type 2. CT/NG PCR (Roche AMPLICOR®) was used for testing 
Chlamydia trachomatis and Neisseriae gonorrhoeae. All Positive results in the primary 
run for the HSV-2 IgG ELISA and CT/ NG PCR were repeated to confirm results. The 
results were then reported on the KICoS laboratory specimen collection and reporting 
form (Appendix D) which is a TeleForm® (Cardiff, 2008) paper form which were then 
scanned and stored in a Microsoft Access database for analysis. In addition, data on 
partner tracing was also collected on the KICoS partner treatment tracking form 
(Appendix E) which is also a TeleForm® paper form. 
KICoS data extracted and reviewed in this study included the following: 
• Information from the behavioural questionnaire completed at baseline screening 
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• Information from STI testing performed at baseline screening (STI panel inclusive of 
neisseria gonorrhoea, chlamydia trachomatis, syphilis and HSV-2) 
• Information on HIV test results from testing performed at baseline 
• Information from participant STI treatment forms 
• Information from partner treatment forms 
• Information from participant medical evaluation forms 
 
The data extracted from the above sources and collected for this study was stored in MS 
Access 2007® as well as Excel 2007® and SAS 9.1® databases. 
3.6. Validity and Reliability 
KICoS data collection tools were designed electronically using QDS® software and 
Teleforms®. Internal checks for consistency and validity were programmed and 
embedded in the design of the questionnaires to ensure data quality. In addition, the study 
staff were trained and the data collection instruments pre-tested, in a one month pilot, 
prior to initiation of data collection. Data entry was automated thus eliminating the need 
for a separate data entry step. Participants were given a tutorial before they could start 
ACASI and also given trial questions to evaluate their competence with the programme 
before the start of the questionnaire. Study staff were also available all the time to assist 
the participant in case of any problems. 
The study clinic and the laboratory adhered to standards of good clinical and laboratory 
practices (GCLP) and the local study-specific standard operating procedures (SOPs) 
manual for proper collection, processing, labelling, transport and storage of specimens. 
Specimen collection, testing, and storage were documented using a Laboratory 
Information Management System (LIMS). For quality assurance purposes, the laboratory 
retested 10% of all specimens tested as well as confirmation of all positive results. The 
laboratory is also enrolled in external quality assurance programmes where 20% of all 
specimens are shipped to external laboratories for validation. 
All study procedures had SOPs detailing the procedures to be followed and regular 
competency tests were administered to staff. Study forms were linked through unique 
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study numbers assigned to study participants and personal identifier information was 
recorded on separate forms and kept separately to maintain confidentiality. Local 
databases are secured with password-protected access systems and access is limited. 
Computerized data records were electronically transferred to a secure password-protected 
network server on a daily basis.  
3.7. Generalisability 
Participants in this study were sampled from participants in KICoS. Since KICoS 
participants were sampled from the general community, the results of this study are 
therefore generalisable for the Kenyan population. 
3.8. Data Analysis 
Data analysis was done using statistical analysis software (SAS) for windows version 9.1 
(SAS Institute, Cary, North Carolina, USA). To describe the baseline demographic 
characteristics of persons screened in the study, frequencies and percentages of 
participants in various socio-demographic groups was computed. The prevalence of STIs 
within KICoS at baseline was calculated for the overall study population at screening in 
order to describe the disease burden. This involved the calculation of overall STI 
prevalence, specific STI prevalence as well as the prevalence of syndromic and 
laboratory diagnosed STIs. 
Bivariate and multivariate logistic regression was used to explore the association between 
risk factors and STI infection. Unadjusted and adjusted odds ratios with their 95% 
confidence intervals were calculated. Unadjusted odds ratios were used for bivariate 
analysis while adjusted odds ratios were used for the multivariate analysis that adjusted 
for the other risk factors that could act as confounders. Risk factors analysed included age 
group, gender, education, employment and marital status, number of spouses, inheritance 
status, type of sexual partners, transactional sex, alcohol and drug use, anal sex, time 
frame of last sex, condom use, circumcision status and STI treatment history and HIV 
status. The first model entailed a bivariate analysis of the presumed risk factors and those 
factors found to be having p values of <0.25 from the bivariate model were then included 
in the multivariate analysis. The cut off p value of <0.25 was chosen based on the works 
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of Bendel and Alfi (1977) and Mickey and Greenland (1989) which showed that this cut 
off point allows for the inclusion of all important variables even though it also has the 
disadvantage of including variables with questionable importance (Hosmer and 
Lemeshow, 2000). 
To evaluate the performance of STI syndromic management against the aetiological 
laboratory diagnosis, a kappa coefficient (to assess agreement of the two methods) was 
computed as well as sensitivity and specificity analysis of the methods used. This was a 
two step process with the first step involving the correlation of the agreement between the 
two methods used to ask the syndromic questions namely the self administered ACASI 
questionnaire and the clinician administered CAPI questionnaire. This step used the 
clinician administered CAPI questionnaire as the gold standard. The second step entailed 
the correlation of the agreement between each of the two methods of syndromic questions 
administration and their corresponding laboratory diagnosed STI as well as the sensitivity 
and specificity of the same procedures. For this step the laboratory diagnosis was used as 
the gold standard. 
To establish the success of partner contact treatment, the number of participants who 
were issued with contact tracing cards was computed against the number of partners who 
actually came for contact treatment. Since the partner treatment is anonymous, linking the 
partners to the index participants was however not done.  
3.9. Ethical Considerations 
KICoS was approved by both the KEMRI Scientific Steering Committee (SSC) and 
Ethical Review Committee (ERC) protocol # 1125 and the CDC Institutional Review 
Board (IRB) protocol #4938. In KICoS, informed consent was obtained from all 
participants. This study was further approved by the University of Western Cape higher 
degrees committee. Confidentiality was also assured for all participants with information 
collected being stored securely at the study clinic. All laboratory specimens, reports, data 
collection instruments, process logs, and administrative forms were identified by a coded 
study identification number to maintain participant confidentiality. All records that 
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contain personal identifiers were stored separately from study records identified by study 
ID and had limited access. All databases were password-protected for security of access. 
3.10. Study Limitations 
This study had the limitation of not including the mode of contact tracing as well as the 
reasons for partners not coming for treatment despite information. In addition the study 
could not link the contacts to the partners so knowing whose partner ever came for 
contact tracing was not possible. This was due to the design of KICoS which did not 
capture this information. 
 
 
 
 
UWC, SOPH Mini-thesis. Fredrick O Otieno, 2632337.   September 2009         21
 
 
 
 
 
 
 
 
 
 
 
CHAPTER FOUR 
RESULTS 
 
 
 
 
UWC, SOPH Mini-thesis. Fredrick O Otieno, 2632337.   September 2009         22
4. RESULTS  
4.1. Introduction 
In this chapter, the results are presented based on data collected from 847 participants and 
the prevalence, risk factors associated with STIs, quality of syndromic diagnosis and 
contact tracing for participants in the study is shown. The results are presented 
thematically focusing on each of the four objectives of the study. The results are also 
summarised in tables and figures. In some tables and figures, the number of participants 
(N) does not total to 847. These are cases where there was no response and in such cases 
the number of participants whose data is analysed is indicated below the tables. 
4.2. Socio-Demographics 
In this section the frequency distributions of the main socio-demographic and socio-
economic characteristics of the participants are presented. The socio-demographics of 
interest here include gender, age, religion, marital status, education and occupation. 
Table I: Socio-Demographic Characteristics of Participants 
Characteristic Frequency  Percentage 
Gender     
Males 422 49.8
Females 425 50.2
Age in Years     
18-19 106 12.5
20-24 530 62.6
25-29 149 17.6
30-34 62 7.3
Religion*     
Roman catholic 318 37.5
Protestant or other Christian 371 43.8
Muslim 27 3.2
Nomiya 45 5.3
Other 60 7.1
No religion 25 3.0
Marital Status§     
Single/Never married 516 60.9
Not married but living as married 72 8.5
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Married 214 25.3
Divorced/Separated 28 3.3
Widowed 13 1.5
Education ¥     
Ever attended school 576 68.0
Never attended school 40 4.7
Level of education*     
Primary 214 25.3
Secondary 312 36.8
Tertiary (technical + college) 263 31.1
University 14 1.6
Occupation     
Students 228 27.1
Farmer 29 3.4
Salaried worker 22 2.6
Casual worker 117 13.9
Self employed 146 17.3
Home maker 62 7.4
Unemployed 212 25.2
Other 26 3.1
*N=846 as 1 participant refused to respond to the question 
¥ N=844 as 3 participant refused to respond to the question 
§ N=843 as 4 participant refused to respond to the question 
 
Table I above presents the socio-Demographic characteristics of the patients in the study. 
Of the total 847 participants included in this study, 422 (49.8%) were males. The average 
age of the participants was 22.9 years with majority (62.6%) of those in this study aged 
20-24 years. Majority (81.3%) of the participant reported to be mainstream Christians of 
whose majority were protestant and other Christian. More than half (60.9%) of the 
participants have never been married with only one third (33.8%) of the participants 
being married or living as married. Majority of the participants (68.0%) reported having 
ever attended school with 589 (69.5%) of them having had more than primary education. 
Students comprised of 228 (27.1%) of the participants. 
4.3. STI Prevalence 
The first objective of this study was to estimate the prevalence of STIs within KICoS 
using laboratory and syndromic diagnosis. The STI prevalence calculated was both for 
syndromic diagnosed and specific laboratory diagnosed STIs. 
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4.3.1. Syndromic STI Prevalence 
This section presents the prevalence of STIs based on syndromic diagnosis of 
participants. This prevalence is presented in Table II and figure II below. The syndromes 
diagnosed included vaginal and or urethral discharge, genital ulcers and lower abdominal 
and or scrotal pain. 
Table II: Syndromic Prevalence of STIs 
Syndromic Prevalence 
Males 
N (%) 
Females 
N (%) 
Vaginal/Urethral discharge 1 (20.2) 33 (7.8) 
Genital ulcers 5 (1.2) 0 (0.0) 
Lower abdominal and scrotal pain 2 (0.5) 13 (3.1) 
Overall 7 (1.7) 41 (9.8) 
1 N=812 as 35 participant refused to respond to the question 
2 N=812 as 35 participant refused to respond to the question 
3 N=839 as 8 participant refused to respond to the question 
 
 
Figure II: Syndromic Prevalence of STIs 
 
Table II and figure II above present data on the syndromic prevalence of STIs. Only 48 
(5.7%) of the participants in this study were diagnosed with any STI by syndromic 
diagnosis with females accounting for 41 of those diagnosed. Of the 34 (4.0%) 
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participants diagnosed with vaginal and/or urethral discharge, 33 of them were females 
and all the 5 (1.2%) participants diagnosed with genital ulcers were males. Participants 
with lower abdominal and/or scrotal pain constituted 15 (1.8%) of the participants with 
13 of them being females.  
4.3.2. Aetiological STI Prevalence 
This section presents the prevalence of STIs based on aetiological laboratory diagnosis of 
participants. The specific STIs diagnosed included gonorrhoea, Chlamydia, syphilis and 
HSV-2. Table III and figure III below presents the participants who were diagnosed with 
STIs aetiologically. 
Table III: Aetiological Prevalence of STIs 
Aetiological Prevalence 
Males 
N (%) 
Females 
N (%) 
Gonorrhoea 0 (0.0) 20 (4.7) 
Chlamydia 13 (3.1) 11 (2.6) 
Syphilis 3 (0.7) 11 (2.6) 
HSV-2 60 (14.2) 191 (44.9) 
Overall 71 (16.8) 207 (48.7) 
 
 
Figure III: Aetiological Prevalence of STIs 
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The laboratory diagnosed 32.8% (278) participants to be having an STI of whom 207 
were females. All the 20 participants diagnosed with gonorrhoea were females with 
males constituting 13 of the 24 participants diagnosed with Chlamydia. HSV-2 accounted 
for 29.6% of the infections with 191 females being infected with HSV-2. Participants 
diagnosed with syphilis were only 1.7% (14) of who only 3 were males.  
4.3.3. STI Co infection 
Table IV and figure IV below presents the findings of participants who were infected 
with more than one STI at the same time. The range of STIs co infected is from 0 to 3. 
Table IV: STI Co infection 
Number of STIs Males 
N (%) 
Females 
N (%) 
0 351 (83.2) 218 (51.3) 
1 66 (15.6) 182 (42.8) 
2 5 (1.2) 24 (5.7) 
3 0 (0.0) 1 (0.2) 
 
 
Figure IV: STI Co infection 
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Of all the participants in the study, 67.2% (569), of whom 351 were males, did not have 
any STI. Of the participants diagnosed with an STI, 248 (29.3%) had one STI with 182 of 
them being females. Participants found to be co infected with 2 STIs were 29 (3.4%), 
majority (24) of whom were females while 1 female had 3 STI co infections at the time 
of diagnosis.  
Table V: Co Infected STIs 
Co infected STIs Frequency Percentage
HSV-2 & Chlamydia 8 26.7
HSV-2 & Gonorrhoea 10 33.3
HSV-2 & Syphilis 11 36.7
HSV-2, Chlamydia & Gonorrhoea 1 3.3
 
Figure V: Co Infected STIs 
 
Of all the STI co infections, HSV-2 was predominant in all the participants co infected 
with any STI. Of all the participants co infected with STIs, 3.3% (1) of them were 
infected withHSV-2, Chlamydia and gonorrhoea and 26.7% (8) were co infected with 
HSV-2 and Chlamydia. A further 33.3% (10) were co infected with HSV-2 and 
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gonorrhoea while 36.7% (11) were co infected with HSV-2 and syphilis. Table V and 
figure V above summarises this data. 
4.4. Risk Factors 
The second objective of this study was to describe the socio-demographic, behavioural 
and health risk factors associated with STIs. Bivariate and multivariate logistic regression 
was used to explore the association between the factors and STI infection. This data is 
summarised in table VI below 
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Table VI: Risk Factors for STI Acquisition 
Variable 
Had STIs 
Bivariate Multivariate 
ORa 
p-value 
AORb 
p-value 
N (%) (95% CI) (95% CI) 
Gender     <.0001   <.0001
    Male (n=422) 71 (16.8) 0.22 (0.14, 0.35)   0.22 (0.11, 0.45)   
    Female  (n=425) 207 (48.7) ref
c   ref   
HIV positive     <.0001   0.0007
    Yes (n=123) 85 (69.1) 6.44 (3.29, 12.63)   4.46 (1.89, 10.56)   
    No (n=724) 193 (26.7) ref   ref   
Highest level of education     <.0001   0.0289
    Primary (n=214) 113 (52.8) 5.39 (2.92, 9.94)   2.85 (1.24, 6.54)   
    Secondary (n=312) 98 (31.4) 2.41 (1.38, 4.23)   2.13 (1.08, 4.22)   
    Tertiary (n=277) 47 (17.0) ref   ref   
Marital status     <.0001   0.0343
    Single (n=516) 108 (20.9) 0.07 (0.02, 0.27)   0.18 (0.03, 1.03)   
    Married (n=286) 137 (47.9) 0.26 (0.07, 0.94)   0.39 (0.07, 2.24)   
    Divorced/Widowed (n=41) 30 (73.2) ref   ref   
Ever circumcised     0.0002   0.5236
    Yes (n=184) 28 (15.2 ref   ref   
    No (n=655) 247 (37.7) 3.48 (1.82, 6.63)   1.34 (0.55, 3.30)   
Last time of sex     0.0009   0.1955
    Within three months (n=677) 200 (29.5) 0.35 (0.14, 0.88)   0.70 (0.22, 2.24)   
    Four to six months (n=58) 26 (44.8) 2.17 (0.52, 9.09)   2.63 (0.42, 16.26)   
    More than six months (n=72) 36 (50.0) ref   ref   
Drug use     0.0013   0.0390
    Yes (n=137) 23 (16.8) ref   ref   
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    No (n=707) 254 (35.9) 3.67 (1.66, 8.09)   3.31 (1.06, 10.29)   
Alcohol use     0.0073   0.4324
    Yes (n=363) 90 (24.8) ref   ref   
    No (n=483) 187 (38.7) 1.85 (1.18, 2.89)   0.77 (0.40, 1.48)   
Sex in exchange for gifts     0.0104   0.2276
    Yes (n=103) 30 (29.2) ref   ref   
    No (n=737) 245 (33.2) 2.44 (1.23, 4.83)   1.86 (0.68, 5.09)   
Ever Inherited     0.0212   0.9329
    Yes (n=45) 24 (53.3) ref   ref   
    No (n=796) 251 (31.7) 0.40 (0.19, 0.87)   1.05 (0.35, 3.18)   
Ever treated for STI     0.0850   0.0660
    Yes (n=131) 58 (44.3) ref   ref   
    No (n=709) 216 (30.5) 0.61 (0.34, 1.07)   0.48 (0.22, 1.05)   
Condom use with main partner     0.0876   0.9000
    All of the time (n=13) 7 (53.9) 1.31 (0.41, 4.22)   0.55 (0.11, 2.65)   
    Most of the time (n=41) 15 (36.6) 0.68 (0.33, 1.42)   0.89 (0.34, 2.30)   
    Sometimes (n=122) 36 (29.5) 0.55 (0.33, 0.90)   0.97 (0.49, 1.93)   
    Never (n=211) 92 (43.6) ref   ref   
Multiple spouses     0.1360   0.1585 
    Yes (n=21) 12 (57.1) ref   ref   
    No (n=824) 266 (32.3) 0.46 (0.17, 1.27)   2.50 (0.70, 8.97)   
Number of sexual partners     0.1494   0.0488 
    No sexual partners (n=59) 16 (27.1) 2.67 (0.63, 11.37)   2.57 (0.48, 13.83)   
    Single sexual partner (n=91) 31 (34.1) 0.56 (0.24, 1.29)   0.35 (0.13, 0.94)   
    Multiple sexual partners (n=696) 231 (33.2) ref   ref   
Age     0.1819   0.7335
   18 - 19 years old (n=106) 25 (23.6) 0.47 (0.18, 1.22)   0.50 (0.13, 1.85)   
   20 - 24 years old (n=530) 163 (30.8) 0.50 (0.24, 1.05)   0.58 (0.20, 1.66)   
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   25 - 29 years old (n=149) 54 (36.2) 0.74 (0.33, 1.68)   0.68 (0.23, 2.00)   
   30 - 34 years old (n=62) 36 (58.1) ref   ref   
Age of sexual debut     0.2845   - 
    < 7 years old (n=17) 4 (23.5) 0.29 (0.02, 3.49)   -   
    8 - 15 years old (n=314) 98 (31.2) 1.28 (0.32, 4.18)   -   
    16 - 21 years old (n=459) 157 (34.2) 1.64 (0.41, 6.55)   -   
    22 - 34 years old (n=26) 9 (34.6) ref  -   
Currently Employed     0.3361   - 
    Yes (n=405) 144 (35.6) ref   -   
    No (n=440) 133 (30.2) 0.81 (0.53, 1.25)   -   
Had anal sex     0.3435   - 
    Yes (n=152) 38 (25.0) ref   -   
    No (n=685) 236 (34.5) 1.30 (0.75, 2.25)   -   
Has regular sex partner     0.4523   - 
    Yes (n=555) 178 (32.1) ref   -   
    No (n=284) 96 (33.8) 1.20 (0.75, 1.90)   -   
Has occasional sex partner     0.5307   - 
    Yes (n=485) 156 (32.2) ref   -   
    No (n=351) 120 (34.2) 1.15 (0.74, 1.80)   -   
Condom use in last sex     0.9859   - 
    Yes (n=265) 55 (20.8) ref   -   
    No (n=579) 221 (38.2) <0.001 (<0.001, >999.99)   -   
a  OR = Unadjusted odds ratios 
b  AOR = Adjusted odds ratios: adjusted for gender, HIV status, level of education, marital status, circumcision status, duration 
of last sex, drug use, alcohol use, sex in exchange for gifts, inheritance, previous STI treatment, condom use with main 
partner, multiple spouses, number of sexual partners and age 
c  ref = reference group 
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4.4.1. Bivariate Analysis 
In the bivariate analysis, being male (OR 0.22; 95% CI, 0.14-0.35), being single (OR 
0.07; 95% CI, 0.02-0.27) or married (OR 0.26; 95% CI, 0.07-0.94) as opposed to being 
widowed or divorced, not being inherited (OR 0.40; 95% CI, 0.19-0.87), having had sex 
within the last 3 months (OR 0.35; 95% CI, 0.14-0.88) as opposed to more than 6 months 
and sometimes using condoms with main partner (OR 0.55; 95% CI, 0.33-0.90) as 
opposed to never using condoms were protective to getting STIs. 
On the other hand having secondary (OR 2.41; 95% CI, 1.38-4.23) or primary (OR 5.39; 
95% CI, 2.92-9.94) education as opposed to tertiary education, taking alcohol (OR 1.85; 
95% CI, 1.18-2.89), not taking drugs (OR 3.67; 95% CI, 1.66-8.09), being uncircumcised 
(OR 3.48; 95% CI, 1.82-6.63), not having sex in exchange for gifts (OR 2.44; 95% CI 
1.23-4.83) and being HIV positive (OR 6.44; 95% CI, 3.28-12.63) were associated with 
getting STIs. 
4.4.2. Multivariate Analysis 
Multivariate analysis was performed on all the variables that had p values of <.25 from 
the bivariate analysis. These variables included gender, age, level of education, marital 
status, inheritance, having sex in exchange for gifts, alcohol use, drug use, time of last 
sex, condom use with main partner, having multiple spouses, number of sex partners, 
circumcision status, ever being treated for STIs and HIV status.  
Being male (OR 0.22; 95% CI, 0.11-0.45) or having a single sexual partner (OR 0.35; 
95% CI 0.13-0.94) was found to have a protective effect from getting STIs. On the other 
hand, having secondary (OR 2.85; 95% CI, 1.24-6.54) or primary (OR 2.13; 95% CI, 
1.08-4.22) education, not using recreational drugs (OR 3.31; 95% CI, 1.06-10.29) and 
being HIV positive (OR 4.46; 95% CI, 1.89-10.56) was found to increase the risk of 
getting STIs. 
4.5. Performance of Syndromic Management 
The third objective of this study was to evaluate the performance of STI syndromic 
management against aetiological laboratory diagnosis. This was done in two steps which 
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included correlation of the agreement between the laboratory and syndromic diagnosis as 
well as the correlation of the two different syndromic questioning methods.  
4.5.1. Correlation between CAPI and ACASI Methods of Interviewing 
The first part of this analysis evaluated the correlation between the two methods of 
identifying the signs and symptoms of STIs based on the syndromic management 
guidelines. These were the clinician administered CAPI and the self administered 
ACASI. Table VII and figure VI summarises this information below. 
Table VII: Kappa Analysis for agreement between ACASI and CAPI responses 
STI Kappa 95% Confidence Levels 
Lower Upper 
Genital Ulcers 0.2642 0.1015 0.4268
Vagina/Urethral Discharge 0.3356 0.1994 0.4719
Scrotal/Lower abdominal pain 0.6454 0.5386 0.7521
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Figure VI: Kappa Analysis for agreement between ACASI and CAPI responses 
 
The agreement between ACASI and CAPI methods of interviewing on the syndromic 
diagnosis of STIs ranged from fair to substantial agreement. Agreement on the diagnosis 
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of genital ulcers (0.26, CI: 0.10, 0.43) and vaginal/urethral discharge (0.34, CI: 0.20, 
0.47) was fair, with that of scrotal/lower abdominal pain being substantial (0.65, CI: 0.54, 
0.75). 
4.5.2. Correlation between Syndromic and Laboratory Diagnosis 
The second part of this analysis evaluated the correlation between the two methods STI 
diagnosis. These methods were the laboratory based aetiological diagnosis and the 
syndromic based CAPI and ACASI syndromic diagnosis. Table VIII and figures VII and 
VIII summarises this information below. 
Table VIII: Kappa Analysis for agreement between ACASI and CAPI responses 
STI CAPI Kappa 
95% Confidence Levels ACASI 
Kappa 
95% Confidence Levels
Lower Upper Lower Upper 
Syphilis 0.0002 0.0000 0.0004 -0.0009 -0.0057 0.0038
Gonorrhoea -0.0023 -0.0079 0.0034 -0.0079 -0.0179 0.0021
Chlamydia -0.0020 -0.0077 0.0037 -0.0032 -0.0114 0.0050
HSV 2 -0.0065 -0.0154 0.0025 -0.0018 -0.0216 0.0181
Overall 0.0567 0.0097 0.1038 0.0560 -0.0052 0.1172
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Figure VII: Kappa Analysis for agreement between Laboratory and CAPI 
responses 
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Kappa Analysis for Agreement Between Laboratory and ACASI 
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Figure VIII: Kappa Analysis for agreement between Laboratory and ACASI 
responses 
Overall, there was no agreement between laboratory and CAPI (0.06, CI: 0.01, 0.10) as 
well as between the laboratory and ACASI (0.06, CI: -0.005, 0.12) diagnosis for STIs. 
There was also no agreement between the laboratory and CAPI as well as ACASI 
diagnosis for the specific STIs. 
4.5.3. Sensitivity and Specificity of CAPI and ACASI Syndromic Diagnosis 
The analysis also evaluated the sensitivity and specificity of the CAPI and ACASI 
syndromic diagnosis with the laboratory aetiological diagnosis being used as the gold 
standard. Overall as well as specific STI sensitivity and specificity was calculated. 
Overall sensitivity was very low in CAPI (8.7%) and ACASI (17.7%) while specificity 
was very high in CAPI (95.8%) and ACASI (87.2%). STI specific sensitivity was 
generally very low across the different STIs with those diagnosed by CAPI being 0.0% 
(syphilis), 7.5% (gonorrhoea), 6.3% (Chlamydia) and 1.2% (HSV 2. ACASI diagnosis 
performed a little better than CAPI with syphilis (7.1%), gonorrhoea (22.5%), Chlamydia 
(12.5%) and HSV 2 (4.4%). STI specific specificity on the other hand performed very 
well with CAPI diagnosis specificity being 99.4% (syphilis), 98.3% (gonorrhoea), 97.2% 
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(Chlamydia) and 99.8% (HSV 2), while ACASI diagnosis specificity being syphilis 
(0.0%), gonorrhoea (7.5%), Chlamydia (6.3%) and HSV 2 (1.2%). 
4.6. Partner Notification and Treatment 
The last objective of this study was to establish the success of partner contact treatment. 
This was based on the tabulation of how many partners of participants actually came for 
STI contact treatment after the participants were issued with contact tracing cards.  
4.6.1. STI Contact Cards Issued 
The first part of this analysis tabulated the number of participants who were issued with 
STI contact tracing cards following them either being syndromic or aetiological 
diagnosed to have a STI. 
Table IX: STI contact cards issued 
STI Contact Cards Issued 
  
Males 
N (%) 
Females 
N (%) Total 
Syndromic Cards 7 (14.6) 41 (85.5) 48 
Laboratory Cards 71 (25.5) 207 (74.5) 278 
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Figure IX: STI contact cards issued 
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Table IX and figure IX above presents the number of participants who were issued with 
STI contact tracing cards both at syndromic and aetiological diagnosis. A total of 48 
participants (7 males and 41 females) were issued with contact tracing cards following 
syndromic management of STI while 278 (71 males and 207 females) were issued with 
cards following aetiological diagnosis. 
4.6.2. STI Contact Treated 
The second part of this analysis tabulated the number of contacts who came for contact 
treatment following their sexual partner being issued with STI contact tracing cards to 
hand over to them. 
Table X: STI contacts treated 
STI Contacts Treated 
  
Males 
N (%) 
Females 
N (%) 
Total 
N (%) 
Syndromic Contacts 0 (0.0) 1 (2.4) 1 (2.1) 
Aetiological Contacts 1 (1.4) 0 (0.0) 1 (0.4) 
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Figure X: STI contacts treated 
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Table X and figure X above presents the number of sexual contacts of participants who 
came for contact treatment at the clinic. Of the contacts of the participants who were 
syndromically diagnosed with STIs, only 1 (2.1%) contact came to the clinic for contact 
treatment. For the contacts of the participants who were aetiologically diagnosed with 
STIs, also just 1 (0.4%) contact came to the clinic for contact treatment.  
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5. DISCUSSION 
5.1. Introduction 
This chapter discusses the key results of this study in relation to the objectives as well as 
to the findings of similar studies. The first section discusses the prevalence of STIs while 
the second section discusses the risk factors to acquisition of STIs. The third section 
discusses the performance of the methods used in the diagnosis of STIs in the study and 
the fourth section discusses the outcomes of partner contact tracing and treatment. The 
last section discusses the study limitations and their probable effect on the results.  
5.2. STI Prevalence 
The overall prevalence of STIs by syndromic diagnosis was found to be 5.7% which is 
lower than that of another population based study by Mosha et. al., (1993) in Tanzania as 
well as a CSW study in Malawi (Zachariah et al., 2003). The prevalence of aetiologically 
diagnosed STIs was found to be 32.8% with 16.8% males and 48.7% females being 
infected. These results are comparable to the Kenya AIDS indicator survey (KAIS) of 
2007 (National AIDS and STI Control Programme, 2009). Specific STIs prevalence was 
also comparable with results being similar for syphilis and HSV-2 after adjusting for age 
since the age range in KAIS was 15-64 years. This prevalence is still high thus presenting 
a need for strengthening the screening and management capabilities of primary health 
facilities in the area.  
Four percent of the participants were diagnosed with vaginal and/or urethral discharge. 
Males constituted only 0.2% of these participants which is lower than that seen in the 
Tanzania study of 28.0% (Mosha et al., 1993). The prevalence of vaginal and/or urethral 
discharge in females is however comparable to that seen in Tanzania at 7.8% but lower 
than that seen in the CSW study of 53% (Zachariah et al., 2003). This is most probably 
because the participants in the CSW study were more probably sexually active than those 
in this study and the Tanzania study.  
The 1.2% prevalence of genital ulcers is lower than that found in the Tanzania study. All 
the participants diagnosed with genital ulcers were males showing that genital ulcers is 
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more prevalent among males which is comparable to the Tanzania study that found the 
prevalence of genital ulcers in males to be almost four fold that of females. Participants 
with lower abdominal and/or scrotal pain constituted 1.8% of the participants in this 
study which is seven times lower than that seen in the Tanzania study. Females had six 
times more lower abdominal and/or scrotal pain than males in this study. This prevalence 
was still lower than that seen in the CSW study in Malawi. 
The prevalence of Chlamydia in this study was found to be 2.8% with that of females 
being 2.6% and males 3.1%. This is higher than the prevalence in the Indonesia study 
(Sabin et al., 2003) of <1%. The prevalence is however lower than that seen in a 
population survey in Gabon of 59.6% (Bertherat et al., 1998) and a rural community 
survey in South Africa of 6.1% (Colvin et al., 1998). This is despite the fact that all the 4 
studies were population based. A sentinel survey among post abortal clinic attendees in 
Mozambique found prevalence of 42.5% which is very high compared to that seen in the 
females in this population (Machungo et al., 2002). 
HSV-2 accounted for 29.6% of the infections with 14.2% being males and 44.9% being 
females in the study. Compared to the 4 cities study (Weiss et al., 2001), the prevalence 
of HSV-2 was comparable, even if we looked at the data for the same population in 
Kisumu. This is however not comparable to the prevalence seen in other studies in 
Malawi (Glynn et al., 2008), Uganda (Charvat et al., 2009) and Tanzania (Langeland et 
al., 1998, Yahya-Malima et al., 2008) which were higher ranging from 33.2% to 42.1% 
among the males and from 20.7% to 80% among females.  
The prevalence of syphilis in this study was 1.7% of whom 2.6% were females and 0.7% 
being males. This is lower than what was seen in the literature reviewed with the 
prevalence being 5.2% in Indonesia (Sabin et al., 2003), 8.8% in South Africa (Colvin et 
al., 1998) and 8.6 in Gabon (Bertherat et al., 1998). A population-based study in Tanzania 
found the prevalence in males to be 8.1% and 9.4% for females (Mosha et al., 1993). This 
is despite the fact that all these studies were population based studies. A sentinel survey 
among post abortal clinic attendees in Mozambique reported a prevalence of 7.9% 
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(Machungo et al., 2002) which is most likely due to the high risk nature of the 
participants in this study.  
STI co infection was generally low with HSV-2 infection being predominant in all the co 
infections. This is most probably due to the untreatable nature of HSV-2 and the lack of 
good diagnostic capabilities for its identification. 
5.3. Risk Factors 
Males and single individuals were found to be at a lower risk of STI acquisition 
compared to their counterparts, while those who had secondary or primary education, did 
not use recreational drugs and were HIV positive were at a higher risk of getting STIs. 
Females were most at risk for STI acquisition mostly probably because of biological 
predisposition since the signs and symptoms of STIs take longer to manifest in them and 
thus they take longer before they seek treatment (Newell et al., 1993, Sabin et al., 2003). 
Education as a risk factor has been found to be both protective and putting people at a 
higher risk of STI acquisition in different studies (Newell et al., 1993, Watson-Jones et 
al., 2007, Solomon et al., 2008). The studies that have higher education as a risk factor 
have demonstrated that with higher education comes associated with increased number of 
sexual partners, which might also be the case in this situation. HIV positivity as a risk 
factor is consistent with most studies (Weiss et al., 2001, WHO, 2001c, Wolday et al., 
2004, Watson-Jones et al., 2007). Many studies that have looked at the use of recreational 
drugs, have shown it to be a risk factor to STI acquisition (Noell et al., 2001, Fenton et 
al., 2005) which is not consistent with data from this study. 
5.4. Performance of Syndromic Management 
There are not many studies that have compared the performance of syndromic diagnosis 
against aetiological diagnosis. This study evaluated a clinician administered syndromic 
evaluation as well as a self administered syndromic evaluation vis a vis the laboratory 
aetiological diagnosis. With the agreement between ACASI and CAPI methods of 
interviewing on the syndromic diagnosis of STIs ranging from fair to substantial 
agreement, it is probable that regardless of whether the syndromic questions were asked 
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by a clinician or the patients were given a self administered questionnaire, they would 
most of the time give almost similar to similar responses.  
This study has failed to validate syndromic diagnosis with aetiological diagnosis. This is 
inconsistent with most studies that have shown syndromic diagnosis to be comparable to 
laboratory diagnosis (Mayaud et al., 1997, Mbofana et al., 2002, Wolday et al., 2004, 
Pickering et al., 2005). This is most probably because most of these studies focused on 
syndromic STI management within STI clinics as opposed to research studies. On the 
other hand, the study has shown the specificity of syndromic diagnosis to be very high 
which brings the advantage of the administration of the correct treatment once diagnosis 
is made. The two methods of syndromic diagnosis also performed relatively well against 
each other showing that volunteered as well as interrogated STI syndromic diagnosis 
would both work well. 
5.5. Partner Notification and Treatment 
The study found the uptake of contact tracing cards to be high with all patients diagnosed 
with STIs being issued with contact tracing cards. This was probably because of the 
protocol requirement to issue the cards and also for the intensive counselling that was 
part of the management. Uptake of contact treatment was however low with only 2.1% 
and 0.4% partners of the syndromicaly and aetiotiologicaly diagnosed participants 
coming for treatment. This was lower than other studies done in Kenya (Wakasiaka et al., 
2003) and South Africa (Young et al., 2007). This is probably either due to participants 
not delivering the cards or the partners opting not to come for treatment or seeking 
treatment for them selves after developing signs and symptoms. 
5.6. Limitations 
Since the study did not include the mode of contact tracing as well as the reasons for 
partners not coming for treatment despite information, identification of the best mode of 
contact tracing was not possible especially since some of the recent studies have shown 
that partner delivered medication has been effective in the management of STIs 
(Kissinger et al., 1998, Kissinger et al., 2005, Kissinger, 2009). The inability of the study 
to link partners to index patients compromised the ability to link index patients with their 
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sexual partners. This made it impossible for the study to track which partners of index 
patients came for treatment so follow up could not be initiated. 
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CHAPTER SIX 
CONCLUSION AND 
RECOMMENDATION 
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6. CONCLUSION AND RECOMMENDATIONS 
6.1. Conclusions 
This study describes the prevalence of, risk factors associated with and the performance 
syndromic diagnosis in the management of STIs within the Kisumu Incidence Cohort 
Study (KICoS) in Kisumu, Kenya. This was done through five objectives. 
The prevalence of STIs by syndromic diagnosis was 5.7% while by laboratory diagnosis 
was 32.8%. In addition, 32.8% of the participants were co infected with 2 or 3 STIs with 
HSV-2 being predominant in all the participants co infected with any STI. This presents 
STIs as a problem in this population that needs addressing. Being female, being HIV 
positive, having lower than tertiary education, using recreational drugs and having 
multiple sexual partners were found to be risk factors to the acquisition of STIs in this 
population and thus should be mitigated. 
The STI syndromic diagnosis generally performed very low against aetiological 
laboratory diagnosis. This was inconsistent with present data but most of this data is from 
studies done in STI clinics. The performance of partner contact tracing and treatment was 
very poor with very few partners coming for treatment even after their index was given 
contact tracing cards 
6.2. Recommendations 
Based on the description of the prevalence of, risk factors associated with and the 
performance syndromic diagnosis in the management of STIs within the Kisumu 
Incidence Cohort Study (KICoS) in Kisumu, Kenya, the following recommendations are 
made: 
1. More emphasis needs to be put in risk reduction strategies to mitigate the spread of 
STIs. 
2. The use of syndromic diagnosis of STIs in research settings need to be reviewed 
further. 
3. There should be increase availability of laboratory services in the diagnosis of STIs 
4. Efforts in partner contact tracing need to be intensified. 
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5. More research is still needed in this area to further understand and address the risk 
factors that predispose people to STI acquisition. 
 
 
 
 
 
UWC, SOPH Mini-thesis. Fredrick O Otieno, 2632337.   September 2009         48
7. REFERENCES 
ABDOOL KARIM, S. S. (1994) Challenges to the control of sexually transmitted 
diseases in Africa. Am J Public Health, 84, 1891-1893. 
BERTHERAT, E., GEORGES-COURBOT, M. C., NABIAS, R., GEORGES, A. J. & 
RENAUT, A. (1998) Seroprevalence of four sexually transmitted diseases in a semi-
urban population of Gabon. Int J STD AIDS, 9, 31-36. 
BLANKHART, D., MULLER, O., GRESENGUET, G. & WEIS, P. (1999) Sexually 
transmitted infections in young pregnant women in Bangui, Central African Republic. Int 
J STD AIDS, 10, 609-614. 
BUVE, A., LAGA, M. & PIOT, P. (1993) Sexually transmitted diseases; Where are we 
now? Health Policy and Planning, 8, 277-281. 
CATCHPOLE, M. (2001) Sexually transmitted infections: control strategies. British 
Medical Journal, 322, 1135-1136. 
CHALAMILLA, G., MBWANA, J., MHALU, F., MMARI, E., MAJIGO, M., SWAI, A., 
URASSA, W. & SANDSTROM, E. (2006) Patterns of sexually transmitted infections in 
adolescents and youth in Dar es Salaam, Tanzania. BMC Infectious Diseases, 6, 22-30. 
CHARVAT, B., SSEMPIJJA, V., KIGOZI, G., SERWADDA, D., MAKUMBI, F., IGA, 
B., LAEYENDECKER, O., RIEDESEL, M., OLIVER, A., CHEN, MICHAEL Z., 
REYNOLDS, S. J., WAWER, M. J., GRAY, R. H. & QUINN, T. C. (2009) Factors 
Associated with the Prevalence and Incidence of Herpes Simplex Virus Type 2 Infection 
among Men in Rakai, Uganda. The Journal of Infectious Diseases, 199, 945-949. 
CHEGE, W., THOMAS, T., OGENDO, A., OTIENO, F., MCLELLAN-LEMAL, E., 
PALS, S., ZEH, C., ACKERS, M., HART, C., LASERSON, K., CHEN, R., KILMARX, 
P. & VULULE, J. (2007) A prospective cohort study to estimate incidence of HIV 
seroconversion and to identify determinants of successful recruitment and retention in 
preparation for an HIV prevention trial among adolescents and young adults in Kisumu, 
western Kenya. KEMRI/CDC. 
CHERSICH, M. F., LUCHTERS, S. M. F., MALONZA, I. M., MWAROGO, P., 
KING'OLA, N. & TEMMERMAN, M. (2007) Heavy episodic drinking among Kenyan 
female sex workers is associated with unsafe sex, sexual violence and sexually 
transmitted infections. Int J STD AIDS, 18, 764-769. 
COHEN, M. S., HOFFMAN, I. F., ROYCE, R. A., KAZEMBE, P., DYER, J. R., DALY, 
C. C., ZIMBA, D., VERNAZZA, P. L., MAIDA, M., FISCUS, S. A., ERON JR, J. J. & 
MALAWI RESEARCH GROUP AIDSCAP (1997) Reduction of concentration of HIV-1 
in semen after treatment of urethritis: implications for prevention of sexual transmission 
of HIV-1. Lancet, 349, 1867-1873. 
COLVIN, M., KARIM, S. S. A., CONNOLLY, C., HOOSEN, A. A. & NTULI, N. 
(1998) HIV infection and asymptomatic sexually transmitted infections in a rural South 
African community. Int J STD AIDS, 9, 548-550. 
 
 
 
 
UWC, SOPH Mini-thesis. Fredrick O Otieno, 2632337.   September 2009         49
DESAI, V., KOSAMBIYA, J., THAKOR, H., UMRIGAR, D., KHANDWALA, B. & 
BHUYAN, K. (2003) Prevalence of sexually transmitted infections and performance of 
STI syndromes against aetiological diagnosis, in female sex workers of red light area in 
Surat, India. Sexually Transmitted Infections, 79, 111-115. 
DOHERTY, I. A., PADIAN, N. S., MARLOW, C. & ARAL, S. O. (2005) Determinants 
and Consequences of Sexual Networks as They Affect the Spread of Sexually 
Transmitted Infections. The Journal of Infectious Diseases, 191, S42-S54. 
DONOVAN, B. (2004) Sexually transmissible infections other than HIV. Lancet, 363, 
545-556. 
DRUMRIGHT, L. N., GORBACH, P. M. & HOLMES, K. K. (2004) Do People Really 
Know Their Sex Partners?: Concurrency, Knowledge of Partner Behavior, and Sexually 
Transmitted Infections Within Partnerships. Sexually Transmitted Diseases, 31, 437-442. 
FENTON, K. A., MERCER, C. H., JOHNSON, A. M., BYRON, C. L., MCMANUS, S., 
ERENS, B., COPAS, A. J., NANCHAHAL, K., MACDOWALL, W. & WELLINGS, K. 
(2005) Reported Sexually Transmitted Disease Clinic Attendance and Sexually 
Transmitted Infections in Britain: Prevalence, Risk Factors, and Proportionate Population 
Burden. The Journal of Infectious Diseases, 191, S127-S138. 
GARG, S., SINGH, M., NATH, A., BHALLA, P., GARG, V., GUPTA, V. & UPPAL, Y. 
(2007) Prevalence and awareness about sexually transmitted infections among males in 
urban slums of Delhi. Indian Journal of Medical Sciences, 61, 269-277. 
GILSON, L., MKANJE, R., GROSSKURTH, H., MOSHA, F., PICARD, J., GAVYOLE, 
A., TODD, J., MAYAUD, P., SWAI, R., FRANSEN, L., MABEY, D., MILLS, A. & 
HAYES, R. (1997) Cost-effectiveness of improved treatment services for sexually 
transmitted diseases in preventing HIV-1 infection in Mwanza Region, Tanzania. Lancet, 
350, 1805-1809. 
GLYNN, J. R., CRAMPIN, A. C., NGWIRA, B. M. M., NDHLOVU, R., 
MWANYONGO, O. & FINE, P. E. M. (2008) Herpes simplex type 2 (HSV-2) trends in 
relation to the HIV epidemic in northern Malawi. Sex Transm Infect, sti.2008.030056. 
GOH, B. T. (2005) Syphilis in adults. Sexually Transmitted Infections, 81, 448-452. 
GROSSKURTH, H., GRAY, R., HAYES, R., MABEY, D. & WAWER, M. (2000) 
Control of sexually transmitted diseases for HIV-1 prevention: understanding the 
implications of the Mwanza and Rakai trials. Lancet, 355, 1981-1987. 
HAWKEN, M., MELIS, R., NGOMBO, D., MANDALIYA, K., NG'ANG'A, L., PRICE, 
J., DALLABETTA, G. & TEMMERMAN, M. (2002) Opportunity for prevention of HIV 
and sexually transmitted infections in Kenyan youth: results of a population-based 
survey. Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology., 31, 
529-535. 
HOLMES, K. K., F.SPARLING, P., MÅRDH, P. A., LEMON, S. M., STAMM, W. E., 
PIOT, P. & WASSERHEIT, J. N. (1999) Sexually Transmitted Diseases, New York, 
McGraw/Hill. 
 
 
 
 
UWC, SOPH Mini-thesis. Fredrick O Otieno, 2632337.   September 2009         50
HOSMER, D. W. & LEMESHOW, S. (2000) Applied Logistic Regression, New York, 
John Wiley & Sons. 
HUGHES, G., CATCHPOLE, M., ROGERS, P. A., BRADY, A. R., KINGHORN, G., 
MERCEY, D. & THIN, N. (2000) Comparison of risk factors for four sexually 
transmitted infections: results from a study of attenders at three genitourinary medicine 
clinics in England. Sexually Transmitted Infections, 76, 262-267. 
JACKSON, D. J., RAKWAR, J. P., RICHARDSON, B. A., MANDALIYA, K., 
CHOHAN, B. H., BWAYO, J. J., NDINYA-ACHOLA, J. O., MARTIN, H. L., JR., 
MOSES, S. & KREISS, J. K. (1997) Decreased incidence of sexually transmitted 
diseases among trucking company workers in Kenya: results of a behavioural risk-
reduction programme. AIDS, 11, 903-909. 
JANSEN, H. A. F. M., MORISON, L., MOSHA, F., CHANGALUCHA, J., TODD, J., 
OBASI, A., RUSIZOKA, M., MAYAUD, P., MUNGUTI, K., MABEY, D., 
GROSSKURTH, H. & HAYES, R. (2003) Geographical variations in the prevalence of 
HIV and other sexually transmitted infections in rural Tanzania. Int J STD AIDS, 14, 274-
280. 
KALICHMAN, S. C., SIMBAYI, L. C., KAUFMAN, M., CAIN, D. & JOOSTE, S. 
(2007) Alcohol Use and Sexual Risks for HIV/AIDS in Sub-Saharan Africa: Systematic 
Review of Empirical Findings Prevention Science, 8, 141-151. 
KAMALI, A., QUIGLEY, M., NAKIYINGI, J., KINSMAN, J., KENGEYA-
KAYONDO, J., GOPAL, R., OJWIYA, A., HUGHES, P., CARPENTER, L. M. & 
WHITWORTH, J. (2003) Syndromic management of sexually-transmitted infections and 
behaviour change interventions on transmission of HIV-1 in rural Uganda: a community 
randomised trial. Lancet, 361, 645-652. 
KISSINGER, P. (2009) Considering the patient in patient-delivered partner therapy. 
Sexually Transmitted Infections, 85, 80-81. 
KISSINGER, P., BROWN, R., REED, K., SALIFOU, J., DRAKE, A., FARLEY, T. A. 
& MARTIN, D. H. (1998) Effectiveness of patient delivered partner medication for 
preventing recurrent Chlamydia trachomatis. Sexually Transmitted Infections, 74, 331-
333. 
KISSINGER, P., MOHAMMED, H., RICHARDSON ALSTON, G., LEICHLITER, J. 
S., TAYLOR, S. N., MARTIN, D. H. & FARLEY, T. A. (2005) Patient Delivered 
Partner Treatment for Male Urethritis: A Randomized, Controlled Trial. Clinical 
Infectious Diseases, 41, 623-629. 
KRAUT-BECHER, J. R. & ARAL, S. O. (2006) Patterns of age mixing and sexually 
transmitted infections. Int J STD AIDS, 17, 378-383. 
LAGA, M., MANOKA, A., KIVUVU, M., MALELE, B., TULIZA, M., NZILA, N., 
GOEMAN, J., BEHETS, F., BATTER, B. & ALARY, M. (1993) Non-ulcerative 
sexually transmitted diseases as risk factors for HIV-1 transmission in women: results 
from a cohort study. Acquired Immunodeficiency Syndrome, 7, 95-102. 
LANGELAND, N., HAARR, L. & MHALU, F. (1998) Prevalence of HSV-2 antibodies 
among STD clinic patients in Tanzania. Int J STD AIDS, 9, 104-107. 
 
 
 
 
UWC, SOPH Mini-thesis. Fredrick O Otieno, 2632337.   September 2009         51
LOW, N., BROUTET, N., ADU-SARKODIE, Y., BARTON, P., HOSSAIN, M. & 
HAWKES, S. (2006) Global control of sexually transmitted infections. Lancet, 368, 
2001-2016. 
MACHUNGO, F., ZANCONATO, G., PERSSON, K., LIND, I., JORGENSEN, B., 
HERRMANN, B. & BERGSTROM, S. (2002) Syphilis, gonorrhoea and chlamydial 
infection among women undergoing legal or illegal abortion in Maputo. Int J STD AIDS, 
13, 326-330. 
MADHIVANAN, P., HERNANDEZ, A., GOGATE, A., STEIN, E., GREGORICH, S., 
SETIA, M., KUMTA, S., EKSTRAND, M., MATHUR, M., JERAJANI, H. & LINDAN, 
C. P. (2005) Alcohol Use by Men Is a Risk Factor for the Acquisition of Sexually 
Transmitted Infections and Human Immunodeficiency Virus From Female Sex Workers 
in Mumbai, India. Sexually Transmitted Diseases, 32, 685-690. 
MALTA, M., BASTOS, F. I., STRATHDEE, S. A., CUNNIGHAM, S. D., PILOTTO, J. 
H. & KERRIGAN, D. (2007) Knowledge, perceived stigma, and care-seeking 
experiences for sexually transmitted infections: a qualitative study from the perspective 
of public clinic attendees in Rio de Janeiro, Brazil. BMC Public Health, 7, 1-8. 
MANAVI, K., BHADURI, S., TARIQ, A. & ON BEHALF OF THE WEST 
MIDLANDS BASHH AUDIT GROUP (2008) Audit on the success of partner 
notification for sexually transmitted infections in the West Midlands. Int J STD AIDS, 19, 
856-858. 
MAYAUD, P., MOSHA, F., TODD, J., BALIRA, R., MGARA, J., WEST, B., 
RUSIZOKA, M., MWIJARUBI, E., GABONE, R., GAVYOLE, A., GROSSKURTH, 
H., HAYES, R. & MABEY, D. (1997) Improved treatment services significantly reduce 
the prevalence of sexually transmitted diseases in rural Tanzania: results of a randomized 
controlled trial. Acquired Immune Deficiency Syndrome, 11, 1873-1880. 
MBOFANA, F. S., BRITO, F. J., SAIFODINE, A. & CLIFF, J. L. (2002) Syndromic 
management of sexually transmitted diseases at primary care level, Mozambique. 
Sexually Transmitted Infections, 78, 1-2. 
MOSHA, F., NICOLL, A., BARONGO, L., BORGDORFF, M., NEWELL, J., 
SENKORO, K., GROSSKURTH, H., CHANGALUCHA, J., KLOKKE, A. & 
KILLEWO, J. (1993) A population-based study of syphilis and sexually transmitted 
disease syndromes in north-western Tanzania. 1. Prevalence and incidence. Genitourin 
Med, 69, 415-420. 
MULLICK, S., WATSON-JONES, D., BEKSINSKA, M. & MABEY, D. (2005) 
Sexually transmitted infections in pregnancy: prevalence, impact on pregnancy outcomes, 
and approach to treatment in developing countries. Sexually Transmitted Infections, 81, 
294-302. 
NASCOP (1994) Kenya National Guidelines for Syndromic Management of Sexually 
Transmitted Infections. Nairobi, National AIDS and STD Control Programme. 
NATIONAL AIDS AND STI CONTROL PROGRAMME (2009) Kenya AIDS Indicator 
Survey 2007: Final Report. Nairobi, Ministry of Health, Kenya. 
 
 
 
 
UWC, SOPH Mini-thesis. Fredrick O Otieno, 2632337.   September 2009         52
NEWELL, J., SENKORO, K., MOSHA, F., GROSSKURTH, H., NICOLL, A., 
BARONGO, L., BORGDORFF, M., KLOKKE, A., CHANGALUCHA, J. & KILLEWO, 
J. (1993) A population-based study of syphilis and sexually transmitted disease 
syndromes in north-western Tanzania. 2. Risk factors and health seeking behaviour. 
Sexually Transmitted Infections, 69, 421-426. 
NOELL, J., ROHDE, P., OCHS, L., YOVANOFF, P., ALTER, M. J., SCHMID, S., 
BULLARD, J. & BLACK, C. (2001) Incidence and Prevalence of Chlamydia, Herpes, 
and Viral Hepatitis in a Homeless Adolescent Population. Sexually Transmitted Diseases, 
28, 4-10. 
PAKIANATHAN, M. R., ROSS, J. D. C. & MCMILLAN, A. (1996) Characterizing 
patients with multiple sexually acquired infections: a multivariate analysis. Int J STD 
AIDS, 7, 359-360. 
PANCHANADESWARAN, S., JOHNSON, S. C., MAYER, K. H., SRIKRISHNAN, A. 
K., SIVARAM, S., ZELAYA, C. E., GO, V. F., SOLOMON, S., BENTLEY, M. E. & 
CELENTANO, D. D. (2006) Gender differences in the prevalence of sexually transmitted 
infections and genital symptoms in an urban setting in southern India. Sexually 
Transmitted Infections, 82, 491-495. 
PEELING, R. W. (2006) Testing for sexually transmitted infections: a brave new world? 
Sexually Transmitted Infections, 82, 425-430. 
PÉPIN, J., DESLANDES, S., KHONDE, N., KINTIN, D., DIAKITÉ, S., SYLLA, M., 
MÉDA, H., SOBÉLA, F., ASAMOAH-ADU, C., AGYARKO-POKU, T. & FROST, E. 
(2004) Low prevalence of cervical infections in women with vaginal discharge in West 
Africa: implications for syndromic management. Sexually Transmitted Infections, 80, 
230-235. 
PICKERING, J. M., WHITWORTH, J. A. G., HUGHES, P., KASSE, M., MORGAN, 
D., MAYANJA, B., VAN DER PAAL, L. & MAYAUD, P. (2005) Aetiology of sexually 
transmitted infections and response to syndromic treatment in southwest Uganda. 
Sexually Transmitted Infections, 81, 488–493. 
SABIN, K. M., RAHMAN, M., HAWKES, S., AHSAN, K., BEGUM, L., BLACK, R. E. 
& BAQUI, A. H. (2003) Sexually transmitted infections prevalence rates in slum 
communities of Dhaka, Bangladesh. Int J STD AIDS, 14, 614-621. 
SMITH FAWZI, M. C., LAMBERT, W., SINGLER, J. M., KOENIG, S. P., LEANDRE, 
F., NEVIL, P., BERTRAND, D., CLAUDE, M. S., BERTRAND, J., SALAZAR, J. J., 
LOUISSAINT, M., JOANIS, L. & FARMER, P. E. (2003) Prevalence and risk factors of 
STDs in rural Haiti: implications for policy and programming in resource-poor settings. 
Int J STD AIDS, 14, 848-853. 
SOLOMON, M. M., SMITH, M. J. & RIO, C. D. (2008) Low educational level: a risk 
factor for sexually transmitted infections among commercial sex workers in Quito, 
Ecuador. Int J STD AIDS, 19, 264-267. 
ST. LAWRENCE, J. S., MONTAÑO, D. E., KASPRZYK, D., PHILLIPS, W. R., 
ARMSTRONG, K. & LEICHLITER, J. S. (2002) STD Screening, Testing, Case 
 
 
 
 
UWC, SOPH Mini-thesis. Fredrick O Otieno, 2632337.   September 2009         53
Reporting, and Clinical and Partner Notification Practices: A National Survey of US 
Physicians. American Journal of Public Health, 92, 1784-1788. 
ST.LAWRENCE, J. S., MONTAÑO, D. E., KASPRZYK, D., PHILLIPS, W. R., 
ARMSTRONG, K. & LEICHLITER, J. S. (2002) STD Screening, Testing, Case 
Reporting, and Clinical and Partner Notification Practices: A National Survey of US 
Physicians. American Journal of Public Health, 92, 1784-1788. 
STEEN, R., VUYLSTEKE, B., DECOITO, T., RALEPELI, S., FEHLER, G., CONLEY, 
J., BRUCKERS, L., DALLABETTA, G. & BALLARD, R. (2000) Evidence of Declining 
STD Prevalence in a South African Mining Community Following a Core-Group 
Intervention. Sexually Transmitted Diseases, 27, 1-8. 
VIVANCOS, R., SCHELENZ, S. & LOKE, Y. K. (2007) Internet treatment of sexually 
transmitted infections – a public health hazard? BMC Public Health, 7, 1-5. 
WAKASIAKA, S. N., BWAYO, J. J., WESTON, K., MBITHI, J. & OGOL, C. (2003) 
Partner Notification in the Management of Sexually Transmitted Infections in Nairobi, 
Kenya. East African Medical Journal, 80, 646-651. 
WATSON-JONES, D., WEISS, H. A., RUSIZOKA, M., BAISLEY, K., MUGEYE, K., 
CHANGALUCHA, J., EVERETT, D., BALIRA, R., KNIGHT, L., ROSS, D. & HAYES, 
R. J. (2007) Risk Factors for Herpes Simplex Virus Type 2 and HIV Among Women at 
High Risk in Northwestern Tanzania: Preparing for an HSV-2 Intervention Trial. JAIDS 
Journal of Acquired Immune Deficiency Syndromes, 46, 631-642 
10.1097/QAI.0b013e31815b2d9c. 
WAWER, M. J., SEWANKAMBO, N. K., SERWADDA, D., QUINN, T. C., PAXTON, 
L. A., KIWANUKA, N., WABWIRE-MANGEN, F., LI, C., LUTALO, T., 
NALUGODA, F., GAYDOS, C. A., MOULTON, L. H., MEEHAN, M. O., AHMED, S., 
GRAY, R. H. & PROJECT STUDY GROUP RAKAI (1999) Control of sexually 
transmitted diseases for AIDS prevention in Uganda: a randomised community trial. 
Lancet, 353, 535-535. 
WEISS, H. A., BUVE, A., ROBINSON, N. J., VAN DYCK, E., KAHINDO, M., 
ANAGONOU, S., MUSONDA, R., ZEKENG, L., MORISON, L., CARAL, M., LAGA, 
M., HAYES, R. J. & FOR THE STUDY GROUP ON HETEROGENEITY OF HIV 
EPIDEMICS IN AFRICAN CITIES (2001) The epidemiology of HSV-2 infection and its 
association with HIV infection in four urban African populations. AIDS, 15, S97-S108. 
WHO (1999) Sexually transmitted infections prevalence study methodology: guidelines 
for the implementation of STI prevalence surveys., Switzerland, World Health 
Organisation. 
WHO (2001a) Global prevalence and incidence of selected curable sexually transmitted 
infections, Geneva, World Health Organisation. 
WHO (2001b) Prevalence survey of sexually transmitted infections among female sex 
workers and Truck drivers in china 1999-2000. Geneva, World Health Organisation. 
WHO (2001c) Prevalence survey of sexually transmitted infections among female sex 
workers and women attending ante natal clinics in Malaysia 1999-2000. Geneva, World 
Health Organisation. 
 
 
 
 
UWC, SOPH Mini-thesis. Fredrick O Otieno, 2632337.   September 2009         54
WHO (2003) Guidelines for the management of sexually transmitted infections, Geneva, 
World Health Organisation. 
WHO (2005) Sexually transmitted and other reproductive tract infections: A guide to 
essential practice, Geneva, World Health Organisation. 
WHO (2007) Global strategy for the prevention and control of sexually transmitted 
infections : 2006 - 2015 : breaking the chain of transmission, Switzerland, World Health 
Organisation. 
WHO (2008) Periodic presumptive treatment for sexually transmitted infections : 
experience from the field and recommendations for research., Switzerland, World Health 
Organisation. 
WILKINSON, D., ABDOOL-KARIM, S. S., HARRISON, A., LURIE, M., COLVIN, 
M., CONNOLLY, C. & STURM, A. W. (1999) Unrecognized sexually transmitted 
infections in rural South African women: a hidden epidemic. Bulletin of the World Health 
Organization, `77, 22-28. 
WOLDAY, D., G-MARIAM, Z., MOHAMMED, Z., MELES, H., MESSELE, T., 
SEME, W., GEYID, A. & MAAYAN, S. (2004) Risk factors associated with failure of 
syndromic treatment of sexually transmitted diseases among women seeking primary care 
in Addis Ababa. Sexually Transmitted Infections, 80, 393-394. 
WORKOWSKI, K. A., BERMAN, S. M. & DOUGLAS-JR, J. M. (2008) Emerging 
Antimicrobial Resistance in Neisseria gonorrhoeae: Urgent Need to Strengthen 
Prevention Strategies. Annals of Internal Medicine, 148, 606-613. 
WORKOWSKI, K. A., LEVINE, W. C. & WASSERHEIT, J. N. (2002) U.S. Centers for 
Disease Control and Prevention Guidelines for the Treatment of Sexually Transmitted 
Diseases: An Opportunity To Unify Clinical and Public Health Practice. Annals of 
Internal Medicine, 137, 255-262. 
YAHYA-MALIMA, K., EVJEN-OLSEN, B., MATEE, M., FYLKESNES, K. & 
HAARR, L. (2008) HIV-1, HSV-2 and syphilis among pregnant women in a rural area of 
Tanzania: Prevalence and risk factors. BMC Infectious Diseases, 8, 75. 
YOUNG, T., DE KOCK, A., JONES, H., ALTINI, L., FERGUSON, T. & VAN DE 
WIJGERT, J. (2007) A comparison of two methods of partner notification for sexually 
transmitted infections in South Africa: patient-delivered partner medication and patient-
based partner referral. Int J STD AIDS, 18, 338-340. 
ZACHARIAH, R., SPIELMANN, M. P., HARRIES, A. D., NKHOMA, W., 
CHANTULO, A. & ARENDT, V. (2003) Sexually transmitted infections and sexual 
behaviour among commercial sex workers in a rural district of Malawi. Int J STD AIDS, 
14, 185-188. 
 
 
 
 
 
UWC, SOPH Mini-thesis. Fredrick O Otieno, 2632337.   September 2009         55
APPENDICES 
Appendix A: Questionnaire extract from ACASI behavioural questionnaire 
Appendix B: CAPI pre-screening for basic eligibility 
Appendix C: CAPI medical history and physical examination 
Appendix D: Extract from KICoS laboratory specimen collection and reporting form 
K411B  
Appendix E: Partner tracking form K318 
 
 
 
 
 
UWC, SOPH Mini-thesis. Fredrick O Otieno, 2632337.   September 2009         56
7.1. Appendix A: Questionnaire Extract from ACASI Behavioural 
Questionnaire 
Participant ID: |__|__|__|__|__|__|__| 
   
Date: |__|__|/|__|__|/|__|__|__|__ 
  dd / mm / yyyy 
Language: 
 01 English 
 02 Swahili 
 03 Luo 
Residence ID 
01 Rural 
02 Urban 
 
Gender (Dem_1): 
01 Male 
02 Female 
 
DEMOGRAPHICS 
Education 
1. Have you ever attended school? 
01 Yes 
00 No 
2. If [Q1=01] What is the highest level of school you attended? 
01 Primary 
02 Post-primary/vocational 
03 Secondary 
04 College (Middle level) 
05 University 
3. If [Q1=01] What is the highest [standard/form/year] you completed at that level? 
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[standard/form/year] ______ 
 
Employment 
4. Are you currently working? 
01 Yes 
00 No 
5. What kind of work do you do most of the time? 
01 Farmer  
02 Salaried worker (e.g. teacher, nurse)  
03 Casual worker  
04 Self-employed  
05 Homemaker  
06 Student  
07 Other (specify: ___________ ) 
6. How many shillings (KES) did you earn in the last 30 days? 
 KES earned________________ 
 
Partnerships/Marriage  
Now, we would like to ask you questions about your marital status. 
24. What is your current marital status?  
01 Single/ Never married  
02 Not married, but living as married  
03 Married  
04 Separated/ Divorced  
05 Widowed 
25. [If Q24 = 01, 04, or 05] Do you currently have a person that you consider a… 
(choose all that apply) 
01 Regular sex partner 
02 Occasional sex partner 
03 One-time sex partner 
04 Someone you get/give money or other gifts for sex 
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26. [If Q24 = 03 and Dem_01 = 01] Do you have more than one wife? 
[If Q24 = 03 and Dem_01 = 02] Does your husband have other wives? 
01 Yes 
00 No 
27. [If Q24 = 01 and Dem_01 = 01] How many total wives do you have right now? 
[If Q24 = 01 and Dem_02 = 01] Including yourself, how many total wives does 
your husband have right now? 
Number of spouses /_ /_ / 
 
Sexual History (Q47-Q66 only asked at baseline) 
The next set of questions focus on sexual intercourse. By sexual intercourse, we mean, 
times that a penis is inside the vagina or anus. We would like you to think about all the 
people that you have had sexual intercourse with. This includes times that you did want 
to have sexual intercourse and times that you did not want to have sexual intercourse.  
Your answers are very important to us. We would like you to be honest and truthful. It 
may make you feel uncomfortable to answer these questions. Please remember that no 
one will know your answers.  
47. When you were a child or teenager, did someone who was older than you or 
someone more powerful than you, ever force you to have sexual intercourse with 
him/her? 
01 Yes 
00 No 
48. [Q47=01] How old were you when this happened? 
Age in years _ _ 
49. [Q47=01] What was the sex of the person(s) who forced you? 
01 Male 
00 Female 
50. [Q47=01] How was this person related to you? 
01 Relative living in the same house 
02 Relative not living in the same house 
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03 Neighbour 
04 Friend 
05 Teacher 
06 Somebody else known to you 
07 Stranger 
51. How old were you the first time that you had sexual intercourse? Please think 
about the very first time, even if it was with someone who had sex with you only 
once, including sexual intercourse during special occasions, or sex with someone 
that you did not want to have sexual intercourse. 
Age |__|__| 
52. When you had sex for the first time, how long had you known each other ? 
01 More than a year 
02 Months 
03 Days 
04 1 day or less 
53. What best describes the first time you had sex. (choose only one) 
01 You wanted to have sexual intercourse 
02 You did not plan on having sexual intercourse, but it happened anyway 
03 You wanted to delay sexual intercourse but felt pressured 
04 You did not want to have sexual intercourse, but you were physically 
forced 
05 You did not want to have sexual intercourse, but you were tricked into 
doing so 
54. Did you have sexual intercourse with this person again? 
01 Yes, but less than 5 times 
02 Yes, 5 times or more 
00   No 
55. What was this person’s relationship to you? 
01 Spouse 
02 Boyfriend/girlfriend 
03 Some other type of friend 
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04 Brother/sister in-law 
05 A relative, living in the same house 
06 A relative, not living in the house 
07 A neighbour 
08 Somebody with authority in the community 
09 Non-relative, but person that you know 
10 Non-relative and a person you never met before 
56. Did this person give you something like money, gifts, or other favours for having 
sexual intercourse with him/her? 
01 Yes, every time 
02 Yes, sometimes or occasionally 
00  No, never 
57.  [If Q56 = 01] What did you receive for having sexual intercourse with him/her? 
(choose all that apply) 
01 Food/non-alcoholic drink 
02 Alcohol 
03 Clothing 
04 School items 
05 Money 
06 Soap, lotion, or hair/beauty products 
07 Other(specify) 
58. Did you use condoms during the first time you had sexual intercourse? 
01 Yes 
00 No 
59. [Q58=00] What was the main reason why you did not use a condom? 
01 Did not know how to use a condom 
02 Did not have a condom available 
03 Trusted my partner 
04 Partner refused to use a condom 
05 Wanted to have a child 
06 Fear using condom 
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07 Other 
60. The first time you had sexual intercourse, was any type of alcohol involved? 
01 Yes 
00 No 
61. The first time you had sexual intercourse, were any drugs involved? 
01 Yes 
00 No 
62. Was the person you had sexual intercourse with for the first time, male or 
female? 
01 Male 
02 Female 
63. What was the age of the person with whom you first had sexual intercourse? 
01 About your age 
02 5 or more years older 
03 5 or less years younger 
For the next questions, please think of all the persons that you have had sexual 
intercourse. 
 
64. With how many different people have you ever had sexual intercourse? 
Number of sex partners/_ /_ / 
65. Please think of all the times that you have had sexual intercourse. Has a man 
ever put his penis to your anus? 
01 Yes 
00 No 
66. Please think of all the times that you have had sexual intercourse. Did you ever 
have oral sex? By oral sex we mean when a woman puts the penis in her mouth 
or the man put his tongue in the vagina. 
01 Yes 
00 No 
 
Recent Sexual Behaviour 
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Thank you for the information you have given us about your sexual history. Please 
remember that to help us find out what puts people at greater risk for HIV infection, we 
need to ask very personal questions. Remember, that your name is not linked to the 
answers you give us and that what you enter into the computer will not be shared with 
anyone.  
The next set of questions will ask you about your sexual behaviour in the past 3 months. 
Please answer these questions honestly. 
67. In the past 3 months, with how many different persons have you had sexual 
intercourse? 
Number of recent sex partners/_ /_ / 
68. In the past 3 months, with how many men or boys have you had sexual 
intercourse? 
Number of male partners/_ /_ / 
69. In the past 3 months, with how many girls or women have you ever had sexual 
intercourse? 
Number of female partners/_ /_ / 
70. Of this/these X person(s) [from Q67], how many do you know or think might 
have HIV? 
Number of HIV+ partners/_ /_ / 
If Q67 = 0, skip to Q83. 
71. How did you find out that this/these person(s) were HIV infected? (choose all 
that apply) 
01 They told me on their own 
02 I asked and they told me 
03 I guessed and they confirmed it 
04 Someone else told me 
05 They looked sick 
06 We got tested together 
07 I went with them to get their test results 
08 Someone from the testing site came looking for them 
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72. In the past 3 months, when you had sexual intercourse with person(s) you know 
or think might have HIV, how often did you use a condom? 
01 Always 
02 Most of the time 
03 Sometimes 
04 Once 
05 Never 
73. If [Q72=05] What was the main reason why you did not use a condom? 
01 Did not know how to use a condom 
02 Did not have a condom available 
03 Trusted my partner 
04 Partner refused to use a condom 
05 Wanted to have a child 
06 Fear using condom 
07 Other 
116. Have you been circumcised? (only asked at baseline) 
Alternative question wording for 3, 6, 9, and 12 month visits: Since your last 
visit, have you been circumcised? 
117. [If Q116 = 00 and Dem_1 = 01] Would you be interested in getting 
circumcised? 
01 Yes 
00 No 
118. [If Q116 = 01] How old were you when you were circumcised? (only asked at 
 baseline) 
 Age |__|__| 
119. Have you ever been treated for a sexually transmitted disease? (only asked 
 at baseline) 
01 Yes 
00 No 
120. [If Q119 = 01] During the past 3 months, have you been treated for a 
 sexually transmitted disease? 
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01 Yes 
00 No 
121. [If Dem_1 = 01] Do you currently have ulcers anywhere on your penis 
 and/or scrotum? 
 [If Dem_1 = 02] Do you currently have ulcers anywhere on your vagina 
 and/or labia? 
01 Yes 
00 No 
122. [If Dem_1 = 01] Do you currently have any pus dripping from your penis 
 and/or a burning pain when passing urine? 
 [If Dem_1 = 02] Do you currently have any abnormal or smelly discharge 
 from your vagina? 
01 Yes 
00 No 
123. [If Dem_1 = 01] Do you currently have pain in your scrotum? 
 [If Dem_1 = 02]Do you currently have pain during sexual intercourse? 
01 Yes 
00 No 
124. Do you clean your genitals after each time you have sexual intercourse?  
01  Yes 
00 No 
If “Yes” to Q.124: How soon after sexual intercourse do you clean your 
genitals? 
01 Right away 
02 Within 5 min 
03 Within 10 min 
04 After 10 min 
If “Yes” to Q.124: What do you use to clean your genitals? 
 01 Dry cloth 
02 Wet cloth without soap 
03 Wet cloth with soap 
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04 Other 
If “Yes” to Q.124: [for females only] how did you clean your genitals? Do you 
say you … 
01 Cleaned inside the genitals only 
02 Cleaned outside the genitals only 
03 Cleaned both inside and outside the genitals 
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7.2. Appendix B: CAPI Pre-Screening for Basic Eligibility 
Participant ID: |__|__|__|__|__|__|__| 
Date: |__|__|/|__|__|/|__|__|__|__ 
  dd / mm / yyyy 
Language: 
 01 English 
 02 Swahili 
 03 Luo 
Visit ID: 01 (Baseline) 
Gender (Dem_1): 
01 Male 
02 Female 
Staff ID: |__|__|__|  
Thank you for your interest in this study. Before we begin, we would like to explain that 
there are many reasons why a person may not be included in the study. Not everyone who 
wishes to get into the study will do so. To help us figure out if you might be included, we 
will need you to answer some basic questions. If the information you give us shows that 
you might be suitable for the study, we will ask you more questions, get a medical history 
from you, and run some medical tests. If your answers to our questions show that you 
should be included and your medical tests show that you are healthy, you will then be 
invited to take part. 
Do you have any questions? 
1. Are you male or female? (Dem_01) 
01 Male 
02 Female 
2. In what day, month and year were you born? [Check National Identification or 
other form of age verification] 
__ __Day 
__ __Month  
__ __Year  
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3. How old were you at your last birthday? 
___ ___ years 
4. Are you currently a resident of: 
01 Kisumu District 
02 Siaya District 
03 Nandi District 
04 Rachuonyo District 
05 Bondo District 
06 Vihiga District 
07 Nyando District 
08 Other District (specify)  
5. In which village/estate do you live? Living in a village/estate is defined as having 
a home that you can go to eat and to sleep everyday. ________________________  
 [Classify as urban or peri-urban/rural according to map] 
6. Within the past two years, has there ever been a time when you moved out of 
[Insert District from Q4] for at least 3 consecutive months? 
01 Yes 
00 No 
7. [If Q6 = 01] What are the reasons that you left [Insert District from Q4]? 
01 Not enough land 
02 Build a new home 
03 Attend boarding school 
04 To look for a job 
05 To start own household elsewhere 
06 To join husband’s family 
07 To join spouse 
08 To further education 
09 Was asked to leave 
10 Personal or community conflict 
11 Committed a crime or harmed someone 
12 Other reason (specify:______) 
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8. [If Q6 = 01] When you moved out of [Insert District from Q4], where did you 
move to? 
01 Another District in Nyanza Province (specify: _________) 
02 Another District in Kenya outside of Nyanza Province (specify: _______) 
03 Outside Kenya (specify: _________) 
Questions 9-13 must be answered YES to take part in screening interview. 
9. If you are found to be suitable to take part in the study, are you willing to come 
in for study visits every 3 months for one year? 
01 Yes 
00 No 
10. If you are found to be suitable to take part in the study, are you willing to give 
study staff detailed information about how they can reach you? 
01 Yes 
00 No 
11. During the past 3 months, have you had sexual intercourse one or more times? 
By sexual intercourse, we mean that the penis enters the vagina or anus. 
01 Yes 
00 No 
12. Are you willing to get an HIV test to take part in this study? 
01 Yes 
00 No 
13. [If Q12 = 01] Are you willing to get the results of your HIV test? 
01 Yes 
00 No 
Questions 14-18 must be answered NO to take part in screening interview. 
14. Do you plan to move away from Kisumu within the next 12 months? 
01 Yes 
00 No 
If [Q14=01] will it be for 3 months or more? 
01 Yes 
00 No 
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15. Are you currently taking part in HIV research where you are receiving an 
intervention? 
01 Yes 
00 No 
16. Do you have any health problems that require ongoing attention by a doctor? 
01 Yes (specify) 
00 No 
17. Have you ever been told by a doctor, nurse, or VCT site that your blood test 
results show that you are infected with HIV, the virus that causes AIDS? 
01 Yes 
00 No 
18. For females: Are you currently pregnant? 
01 Yes 
00 No 
19.  For females: [Q17=00] Do you intend to become pregnant within the next 12 
months? 
01 Yes 
00 No 
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7.3. Appendix C: CAPI Medical History and Physical Examination 
SECTION Bf: GENITOURINARY 
Bf1. Do you currently have ulcers anywhere on your genitals?  
1 Yes 
 0 No 
 8 Refuse to Answer 
Bf2. Do you currently have any discharge in your penis (males) or vagina 
(females)?  
1 Yes 
 0 No 
 8 Refuse to Answer 
Bf3. Do you currently have lower abdominal pain (females) or pain in your 
scrotum (males)?  
1 Yes 
 0 No 
 8 Refuse to Answer 
SECTION D: PHYSICAL EXAMINATION 
Da10. (Applicable to Women Only) [Instruction to the Clinician] Enter pregnancy test 
results (Choose one) 
 1 Positive 
 2 Negative 
 9 Not Applicable 
If VISITID is greater than 1, then skip to Dg1. 
SECTION Dg: GENITOURINARY 
Dg1. [Instruction to the Clinician] Are genital ulcers present?  
1 Yes 
 0 No 
 8 Refuse to Answer 
Dg2. [Instruction to the Clinician] Is vaginal or urethral discharge present?  
1 Yes 
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 0 No 
 8 Refuse to Answer 
Dg3. [Instruction to the Clinician] Is tenderness in the lower abdomen or scrotum 
present?  
1 Yes 
 0 No 
 8 Refuse to Answer 
Dg4. (Ask of Men Only) [Instruction to the Clinician] Circumcision present? 
 1 Yes 
 0 No 
 8 Refuse to Answer 
If VISITID is greater than 1, then skip to E1. 
SECTION E: CLINICIAN'S NOTES 
E1. [Instruction to the Clinician]  Is there a diagnosis made?  
1 Yes 
 0 No 
If E1 is equal to 0, then skip to E116. 
E2. [Instructions to the Clinician]  What is the diagnosis? 
 __ __ __ __ __ __ __ __ __ __ __ __ __ __ __ __ __ __ __ __ __ __ __ __ __ __  
E3. [Instruction to the Clinician]  Please enter the diagnosis code for [Response to 
E2].  __ __ __ __ __ 
 99999 Not Applicable Skip to instruction before Q2 
E4. [Instruction to the Clinician]  Are you giving a prescription for [Response to 
E2]? 
 1 Yes 
 0 No 
If E4 is equal to 0, then skip to E24. 
E5. [Instruction to the Clinician] Enter the medication prescribed for [Response to 
E2]. __ __ __ __ __ __ __ __ __ __ __ __ __ __ __ __ __ __ __ __ __ __ __ __ 
E6. [Instruction to the Clinician] Enter the prescription medication code for 
[Response to E5].  __ __ __ __ __ 
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   99999 Not Applicable Skip to instruction before Q2 
E7. [Instructions to the Clinician]  What is the expiration date? 
 __ __ / __ __ / __ __ __ __ mm / dd / yyyy 
 2099 Not Applicable (Year) 
E8. Instructions to the Clinician]  What is the medication start date? 
 __ __ / __ __ / __ __ __ __ mm / dd / yyyy 
 2099 Not Applicable (Year) 
E9. [Instruction to the Clinician]  Are you giving another prescription for 
[Response to E2]? 
 1 Yes 
 0 No 
If E9 is equal to 0, then skip to E24. 
E10. [Instruction to the Clinician] Enter the medication prescribed for [Response to 
E2].__ __ __ __ __ __ __ __ __ __ __ __ __ __ __ __ __ __ __ __ __ __ __ __ 
E11. [Instruction to the Clinician] Enter the prescription medication code for 
[Response to E10]. 
 __ __ __ __ __ 
 99999 Not Applicable Skip to instruction before Q2 
E12. [Instructions to the Clinician]  What is the expiration date? 
 __ __ / __ __ / __ __ __ __ mm / dd / yyyy 
 2099 Not Applicable (Year) 
E13. Instructions to the Clinician]  What is the medication start date? 
 __ __ / __ __ / __ __ __ __ mm / dd / yyyy 
 2099 Not Applicable (Year) 
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7.4. Appendix D: Extract From KICoS Laboratory Specimen Collection and 
Reporting Form K411B  
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7.5. Appendix E: Partner Tracking Form K318 
 
Kisumu Incidence Cohort Study 
Partner Treatment Tracking Form 
   Form K318 
 
 
 
 
O Male   OFemale             Age_._ 
Date: _____________ 
 (dd/mm/yyyy)        Colour 
 
O Male   OFemale                Age_._ 
Date: _____________ 
 (dd/mm/yyyy)        Colour 
 
O Male   OFemale                Age_._ 
Date: _____________ 
 (dd/mm/yyyy)        Colour 
 
 
 
 
Instructions: - For Partners bringing an STI code card. Indicate the partner’s sex and age (in 
years).Indicate the date of visit and mark the first letter of the colour indicated 
on the STI card.  
Completed by:         Date Completed   
Staff Code: 
   
    Signature _____________________________ 
  
  
  
 
    
 
                       dd/ mm/ yyyy 
 
Reviewed by:         Date Reviewed   
Staff Code: 
   
   Signature _____________________________  
  
 
  
 
    
dd/ mm/ yyyy
 
 
 
 
